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Abstract 
Bioprocess development is very labour intensive, requiring many experiments to 
characterize each unit operation in a process sequence to achieve product safety and 
process efficiency. Recent advances in microscale biochemical engineering have led 
to automated high throughput experimentations. The activities for bioprocess 
development are implemented sequentially in which 1) liquid handling system 
performs the wet lab experiments; 2) standalone analytical devices detect the data; and 
3) specific software is used for data analysis and experiment design. The experiment 
design, data analysis and process understanding require substantial engineer’s time. It 
becomes one of the time consuming bottlenecks in bioprocess development 
particularly when a high number of experiments are needed to explore a large design 
space in order to discover high process performance.  
This thesis addresses this challenge by reducing the development time yet achieving 
high process efficiency.  A closed-loop learning approach has been adopted in 
bioprocess design in which the design objectives are driven iteratively by intelligent 
data acquisition. A framework that brings all of the elements performed manually into 
an automated fashion has been established to deliver the closed-loop learning 
approach. Based on the framework, a novel prototype of Intelligent Automation 
Platform for Bioprocess Development (IAPBD) has been built using multi-agent 
architecture. A rational database and four agents including Coordinate Agent, 
Experiment Design Agent, Execution Agent and Assay Agent have been designed to 
perform individual tasks and worked as a team to deliver the bioprocess design 
objectives. The multi-agent architecture used a blackboard mechanism to connect the 
four agents so that they are able to communicate with each other during operations. 
Starting with a set of initial experiments from the user or database, IAPBD is able to 
drive the robotic arm to perform defined initial experiments, and drive the analytical 
devices to detect the data after the experiments are completed. Then it will pick up the 
data from the analytical devices, and carry out data processing and process evaluation 
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based on the optimization objective to achieve the design solution. After evaluation of 
the design solution, it will decide to stop or continue to design the next round 
experiments for optimization.  
The prototype has been evaluated first by a lysozyme precipitation process design, 
which involves typical microscale experimental procedures such as mixing, shaking, 
sample preparation and high throughput data detection instruments. All of the devices 
used have programmable interface so agents can control them directly. An optimal 
design solution that maximizes the yield of lysozyme and maximizes the ammonium 
sulphate concentration was found within a few of iterations using simplex search 
algorithm or Artificial Neural Network (ANN) and the whole tasks were completed 
automatically without human intervention. The success of this case study proved the 
concept of IAPBD. 
The second case study was designed to further evaluate the prototype by the 
precipitation for monoclonal antibody purification. A new “watcher” algorithm in the 
Assay Agent has been further developed to communicate with instruments that do not 
have programmable interface e.g. HPLC. IAPBD carried out two sets of precipitation 
experiments automatically. The “watcher” algorithm has been proved robust and 
efficient to retrieve the data from HPLC.  
The third case study is designed to use the sequential Design of Experiment method to 
optimize the production of a whole cell biocatalyst in fermentation. An optimal 
solution for medium composition and operating conditions was found successfully.  
It was then confirmed by large scale fermentation experiment that the optimal solution 
has increased the biomass/product more than 5 folds. 
The benefit of this novel IAPBD is its automation that reduces the bioprocess design 
time significantly and frees engineer’s time for other intellectual tasks. Prove-of- 
concept of IAPBD has been achieved with limited real experimental evaluation. With 
further development and evaluation, its potential to significantly reduce the time and 
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cost of the whole bioprocess development may be realized.  
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Chapter 1 Introduction 
 
1.1 Perspective and motivation 
Bioprocess development is to identify a robust operation space for a sequence of unit 
operations to produce, recover and purify a specific bioproduct and to achieve a 
desired yield and purity. It requires experiments to understand the impact and 
interaction of the process parameters of the whole bioprocess. Usually, a considerable 
number of experiments are needed for screening the feasible design space, which 
would consume lots of processing materials and time. The two resources are limited in 
bioprocess development, especially at the early stage. Hence, scientists have 
developed high throughput approaches of implementing experiments, which only 
requires small volume of processing materials to produce the results fast. Initially 
developed for drug discovery research where thousands of compounds are tested to 
identify drug candidates, the concept of high throughput approach has been adapted in 
the last decade to reduce the time and cost in bioprocess development. A series of unit 
operation ultra scale down (USD) technologies have been developed in which a 
microscale device is used to mimic the key features of a large scale operation (Tustian 
et al. 2007; Neal et al. 2003; Ma et al. 2009). It allows various combinations of 
parameters to be studied quickly at same time. In an example of investigating the best 
combination of buffer concentrations and pH value to capture polyclonal antibody by 
multi-mode resin (Chhatre & Titchener-Hooker 2009; Chhatre et al. 2010), 80 
three-parameter combinations were studied in parallel. It demonstrates that the high 
throughput approach can implement experiments in parallel to generate process 
relevant experimental data quickly for bioprocess design and development.  
Microscale systems have been most widely studied for bioprocess development based 
on microwell plate and automated liquid handling systems (LHS). An automated LHS 
is programmable to perform required experimental procedures. The robotic arm on 
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LHS is software-driven to perform addition and removal of liquids among different 
wells and to transport microwell plates between the attached automated devices. Such 
devices include shakers, vacuum separators, centrifuge, incubator etc. The automated 
system is then capable of doing most of the microscale experiments automatically for 
both up-stream such as E. coli growth kinetics and recombinant enzyme expression 
and downstream bioprocesses such as precipitation and chromatography with 
pre-packed micro column attached to pipetting tips on LHS (Micheletti & Lye 2006; 
Ferreira-Torres et al. 2005a; Knevelman et al. 2010; Titchener-Hooker et al. 2008). 
Several examples have been published to indicate that micro scale systems have 
shortened the bioprocess development time because of high throughput 
experimentation on microwell plate (Titchener-Hooker et al. 2008; Susanto et al. 
2009).  
The advances in automated system have also raised new challenges in bioprocess 
development. First, the development of high throughput assays does not match the 
rapid pace of experiment execution. Currently, the high throughput experimentation 
by liquid handling system is carried out and then the data is analysed to understand the 
process. Often 96 experiments are run in parallel on a 96-well plate, using statistic 
experiment design method (DoE) to screen a wide design space. Several replications 
of the experiments may be required to ensure the accuracy of experiments at micro 
scale. Therefore, hundreds of experiments are designed and executed simultaneously 
on such automated platforms. However, the development of high throughput assays 
does not match the rapid pace of experiment execution. For example, in monoclonal 
antibody (mAb) precipitation experiments, it took 30 minutes to run 96 experiments in 
a microwell plate but required more than 30 hours to detect mAb concentrations and 
total protein concentrations of the samples from 96 experiments. Although advanced 
HPLC systems with the ultra pressure or low volume have reduced the assay time, 
there is still a mismatch between time on experiment execution and time on assay in 
most bioprocess studies. Besides mAb and total protein concentrations, a large 
number of parameters for product and impurities such as nucleic acid and host cell 
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proteins need to be measured to characterize complex biological drugs. However, 
most biological assays need sample preparation and are time consuming.  
The second challenge is data analysis and experiment design. The LHS is capable of 
carrying out 96 or 384 experiments in parallel by benefiting from microscale 
experimentation technology. After experimentation and assay, data analysis is the key 
step in bioprocess design. However, the software applications in automated 
instruments include data analysis modules for data treatment but are not designed to 
guide further experiment design or process understanding. For instance, the algorithm 
in ChemStation (Agilent Technologies, California, USA), which supports the Agile 
HPLC instrument, can intelligently recognize the peaks and calculate the areas. More 
sophisticated data analysis software applications capable for design and analysis 
experiments such as Design-Expert from Stat-Ease Software (Minneapolis, MN), 
however, are stand-alone software and not integrated with automated systems. 
Therefore when the dataset is large, researchers often take substantial time for data 
analysis, process evaluation and process understanding. The new experiment design 
requires the user’s inputs which come from the process understanding, e.g. which area 
should be explored, which variables should be studied, and what limits of variables are. 
Therefore, data analysis step becomes a potential bottleneck in bioprocess 
development. Hence, data analysis as well as experiment design need to be automated 
to further reduce the time and cost and improve the efficiency of the current practice.  
The time needed for experiments and assays is dependent on the nature of the 
experiments and analytical instruments. Little space is available for time reduction. 
However different strategies for experiment design can lead to very different 
outcomes. In addition, automation of data handling and process evaluation can help us 
to eliminate the time wasted in data handling and software handling. Therefore, the 
current state of the art on high throughput technology, data analysis methods and 
automation technology will be reviewed. 
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1.2 High throughput laboratory automation devices 
The laboratory automation has been developed for last few decades. Typically, a 
laboratory automation system consists of robots, conveyor systems, machine vision, 
and computer hardware and software (Markin 1992). For bioprocess development, the 
common devices adapted in automated high throughput systems are for liquid 
handling, separation equipment, and signal detection. A review of current state of the 
art on the high throughput laboratory automation is given below. 
 
1.2.1 Microwell plate 
In 1951, the first microplate originated as a micro-machined 8*12 array in acrylic. 
Later the first molded 96-well plate was produced. Since then, microplates entered 
common usage. Later in 1996, the Society for Biomolecular Screening proposed 
standardization of micro-plate dimensions with a center-to-center well spacing of 9 
mm in 96 wells (Mannhold et al. 2006). The standard microplates are 86 × 128 × 14 
mm3. Typically, the plates contain 6, 12, 24, or 96-wells of variable geometry and 
volume, but 384, 1536 and now 3456-well plates are available for ultra high 
throughput screening (UTHS) applications. The volume of each well ranges from tens 
of nanolitres to several mililitres. Wells can be either circular or square. The 
standardization of microwell plates from late 1990s allows interoperability between 
plates, instrumentation and equipment from different suppliers This standardization is 
particularly important and provides the base for laboratory automation.  
Microwell plates are being used for every major application in life science researches, 
which involves filtration, separation, optical detection, storage, reaction, mixing and 
cell culture. For example, UV transparent microwell plates enable automated plate 
reader to detect UV absorption of all wells in one run. Developed in early 1980s, 
microwell plates with an embedded layer of filter material make them possible to 
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perform microscale filtration in parallel on automated systems. The introduction of 
“tissue culture treated microplates” further helps studies of live cells that grow inside 
the microwells. The surface of these plates is modified using an oxygen plasma 
discharge to make their surface more hydrophilic so that it becomes easier for adherent 
cells to grow on the surface which would otherwise be strongly hydrophobic. 
 
1.2.2 Liquid handling system (LHS) 
Liquid handling system is widely used in high throughput technologies. Usually it is a 
robotic arm that dispenses a selected quantity of reagent, samples or other liquid to a 
designated container. The simple function is to dispense an allotted volume of liquid 
from a motorized pipette or syringe. However, complicated functions can also be 
implemented by the liquid handling system, e.g. plate handling. 
Many commercial robotic arms are commercially available. Their specific properties 
are listed in Table 1.1. The number and dispense volumes represents the throughput 
which LHS can achieve. The function of liquid level sensing can increase the 
reliability of the systems. Other special features listed in Table 1.1 demonstrate the 
ability of the system to integrate with other devices, e.g. washer, shaker, vacuum 
pump. 
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Table 1.1 Comparisons of main liquid handling systems (Lye et al. 2003) 
Manufacturer and main product Pipettes Dispense volume Plate positions Liquid level sensing Plate handling Special features 
Beckman Coulter 
Biomeck FX workstation 
8, 96, 384 1-250 µL 12 Yes Yes Barcode reader, heating /cooling shaking. Two pipette heads 
operate at the same time. Gripper can assemble/ disassemble 
vacuum filtration manifold. 
Cartesian Technologies 
SQ series workstations 
1, 4, 8, 96 20 nL to 250 µL Up to 19 No Optional Very high speed, as dispenses ‘on the fly’ as the head passes over 
the wells. Optional plate loader can increase the capacity of the 
workstation 
Gilson 
Cyberlab C-400 workstation  
1, 8, 96 1-100µL 36 No Yes Gripper tool, vortex mixing of multiple plates, heater/chiller 
Hamilton Company 
MICROLAB 4000 series 
4, 6, 8, 12, 48, 
96 
1 µL to 25mL 38 Yes Optional Gridding head for transfer from microplates to membranes, agar 
filters and inoculation of daughter plates. Solid phase extraction set 
up. 
Robbins Scientific 
Tango series workstations 
1, 8, 12, 96, 
384 
<1-200 µL 12 No No Computer controlled plate positioning stage. Automated washing 
system. Disposable heads. 
Tecan 
Genesis Workstation 
4, 8 10 nL to 5 mL 20 Yes Yes Six slot shaker incubator, and integrated washing. Up to three 
heads working at the same time. 
TOMTEC 
Quadra series workstations 
4, 8, 96, 384 300 nl to 450 nl 8 No Yes Up to two heads operate at the same time. Shutting system means 
plate capacity is well above the deck capacity. 
Zymark 
Scictone workstation 
8, 96, 384 500 nl to 25 µL 20 No Optional Disposable heads. Deck easily accessible from all four sides 
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The main concerns of the liquid handling systems currently are reliability, displacement 
techniques and integration with other automated devices (Felton 2003; Kong et al. 2012). 
Among these topics, the integration has attracted most attention. Integration is to link LHS 
with other relevant automated devices for biochemical experimentation, e.g. shaker, 
incubator and centrifuge. The advantage of the integration is that the automated system can 
perform more complicated experiment procedures other than liquid handling, so that human 
errors can be avoided. For laboratory automation, instead of purchasing a whole customized 
complex system, nowadays the trend is to acquire a number of different devices and 
components and integrate them together. The reason is that few manufacturers are capable of 
providing these integrated customized workstations, and these workstations are not cost 
effective in most cases (Kong et al. 2012).  
Unfortunately, the components and devices for integration are often from different suppliers 
and no consideration is given to the integration, which makes integration a challenge. The 
automated devices, e.g. LHS, usually come with software that can control and monitor the 
devices. Very few of suppliers actually publish interfaces for third party program to interact 
with either their software or their device. It is difficult to work with a customized system that 
aims to integrate more than one device together. Some suppliers do provide options for the 
integration. For example, the software called EVOware from Tecan can simultaneously 
control several devices including LHS, vacuum separator and plate reader. However, such 
integration functionalities are largely limited within the devices from the same suppliers. For 
instance, EVOware can only control devices from Tecan. Thus, it is still a challenge to 
integrate the lab devices from different suppliers in most cases. Without the integration 
laboratory automation can not be realized. 
 
1.2.3 Separation equipment for microwell plate 
Centrifugation and filtration are common primary recovery procedures in bioprocess 
downstream process. Both separation operations are used in current high throughput 
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screening systems.  
The centrifuges used in the high-throughput screening platform are similar to the common 
centrifuges where the processing materials are separated by gravity forces. These 
centrifuges integrated to the automated system are capable to operate with microwell plates, 
i.e. the centrifugation tasks can be programmed and the liquid handling system can deliver 
such tasks. 
The filtration equipment consists a filter plate and a vacuum separation instruments.  Due to 
the introduction of micro filter plate, different from the tradition harvester, the contents of 
microwell plate can be filtered individually through filter plate by a vacuum pump. The 
vacuum separation modules (Te-VacS) manufactured by Tecan is an example of such 
techniques. The cross-section of a single vacuum filtration manifold showing a 96-well filter 
plate and individual permeate collection tubes is given in Figure 1.1(Jackson et al. 2006). 
The modules are designed to automate cartridge-based and solid phase extraction processes. 
The devices can also be integrated with liquid handling system.  
 
 
 
Figure 1.1 An automated filtration setup.  
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1.2.4 Signal detection 
Owing to the increasing number of types of assay format, the devices involved in signal 
detection are the most diverse part of automated high throughput systems. But for high 
throughput purpose, majority of assays rely on radiometric, fluorimetric, colorimetric or 
lumiometric detection systems. Several instrument manufacturers have developed very 
effective microwell plate based devices covering colorimetric, flourimetric and 
luminometric detection. 
The optical plate reading devices are playing major role in signal detection. With UV 
transparent microwell plate, the plate reader is capable of measuring optical signals of 96 or 
384 samples in one run. At the same time, a lot of assays based on optical signals have been 
developed for bioprocess development, e.g. bovine serum albumin (BSA) assay to measure 
total protein concentration, K-ACET assay from Megazyme (Wicklow, Ireland) to measure 
acetic acid concentration. High throughput and large number of applications make optical 
plate reading device an attractive assay solution for integrated automation systems.  
 
1.2.5 Integrated robotic arm and workstation 
In 1961, the first industrial robot, called Unimate, developed and patented by Unimation Inc. 
was used for die-casting (Kumar 1998). It initiated a technological revolution in robotics. 
Subsequent improvements in computer control and gradual size reductions by automation 
industry and the U.S. space program development during the 1960s and 1970s gave rise to 
robotic devices that were attractive for clinical laboratory applications (Boyd 2002). Then in 
early 1980s, clinical laboratories actually began to use robotics and other automation 
technology to deal with thousands of samples a day. The applications were largely related to 
automated liquid handling robot for sample preparation. 
After decades’ development, the lab automation is becoming an integrated system, which is 
capable of managing sequential complex tasks rather than a one-job workstation. Thus, 
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more and more researchers begin to focus on the structure of the system. The concept of total 
laboratory automation is the use of automated devices and robots to perform all phases of 
clinical laboratory testing. A fully integrated solution called ”Total Laboratory Automation” 
(also referred as fully integrated robotic system) was first introduced from US and later 
rapidly developed in Japan  (Sasaki et al. 1998).  
A fully integrated workstation is a collection of diverse peripheral instruments, which are 
served by an articulated robotic arm or conveyor to move plates between devices (Sasaki & 
Sugiura 2000). Such systems are controlled by scheduling software and capable of 
performing many different procedures such as assays. Earlier systems were room sized and 
were configured to perform a relatively limited range of high throughput screening assay 
methods. Figure 1.2 shows an example of such a fully integrated workstation served by a 
robotic arm. The independent automated devices like specimen manager, centrifuge and 
analyzer are linked by an articulating robotic arm. The robotic arm can transfer the 
microplate among different devices to perform different tasks. 
 
 
Figure 1.2 A fully integrated workstation served by a robotic arm.  
 
Another type of workstation is a ‘turnkey workstation’ which is designed for performing an 
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entire automated process without human intervention (Hüser et al. 2006). The system 
includes pre-validated protocols for reagent/assay applications and the software for the 
specific applications. PAMPA Evolution invented by pION Inn is a good example of such a 
turnkey workstation (Galinis-Luciani et al. 2007). It is a turnkey workstation for sample 
preparation and reading, data analysis, and presentation in a parallel artificial membrane 
permeability assay. 
In comparison, the fully integrated workstation is less intelligent than the turnkey 
workstation. The ‘turnkey workstation’ has created the closed learning and data analysis 
capacities to some level. However, it lacks flexibilities since the turnkey workstation is 
designed for pre-validated applications. It is good for specialise applications. 
 
1.2.6 Application of high throughput techniques in bioprocess development 
High throughput approaches have been applied to the study of many unit operations in a 
whole bioprocess sequence (Micheletti & Lye 2006). But most studies are still focusing on 
the upstream process development. A large number of researches focus on the high 
throughput screening (HTS) which is an essential part of drug discovery and development 
(Gribbon & Andreas 2005; Mishra et al. 2008). Many studies have contributed to microbial 
fermentation (Kostov et al. 2001; Rios-Solis et al. 2013). However, by taking the advantage 
of recently developed liquid handling systems, several examples are published to 
demonstrate that high throughput technology may shorten the development time of 
downstream process such as sample preparation (Saitoh & Yoshimori 2008), precipitation 
(Knevelman et al. 2010; Titchener-Hooker et al. 2008) and chromatography (Chhatre et al. 
2010; Wiendahl et al. 2008). 
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1.2.6.1 Fermentation 
The automated experimentation on fermentation studies has centred on either quantification 
of E. coli growth kinetics (Rios-Solis et al. 2013; Ferreira-Torres et al. 2005b) or medium 
optimization (Micheletti & Lye 2006).  
The experimental setup usually involves LHS, deep-well mircoplates, shaker, and 
incubators. After media preparation step is completed by LHS, fermentations can be run in 
parallel in incubators. The shaking speed can control the oxygen to some extent.  
However, in standard deep-well microplate, dissolve oxygen limits the growth of cells, 
which is not quite same as the larger scale environment. In order to overcome the limitation, 
several customized microwell plates has been introduced to better mimic the performance in 
larger bioreactor (Szita et al. 2005; Puskeiler et al. 2005). 
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Figure 1.3 A customized 48 microwell bioreactor with impeller to increase dissolved 
oxygen level. (a) First prototype with free floating, magnetically driven impellers. (b) 
Second prototype with hollow shaft (Puskeiler et al. 2005). 
 
The studies have shown that the micro scale fermentation performed on microwell plate can 
mimic the large scale process, and the results gained from micro scale experimentation 
provide useful guidance on large scale production optimization.  Researchers are starting to 
overcome the limitation of dissolved oxygen level in microwell plate in order to further 
explore the potential of micro scale fermentation. An example is a customized 48 microwell 
bioreactor with impeller to increase dissolved oxygen level shown in Figure 1.3.  
The uses of mirowell plates with standard size make them very convenient to perform on 
automated system with LHS. However, the increasing volume of data generated by those 
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high throughput experimentation techniques makes data analysis a potential bottleneck to 
slow down the micro scale fermentation process development. Thus, an integrated and 
automated data analysis module is needed to match the increasing throughput. 
 
1.2.6.2 Sample preparation 
The automated sample preparation process has been demonstrated in several prototypes of 
total laboratory automation (Sasaki & Sugiura 2000). Generally, the concept of sample 
preparation refers to the ways in which a sample is treated prior to its analysis, and it usually 
includes the following steps: 
 
· Weighing 
· Dissolving 
· Dilution 
· Sample distribution to microwell plates 
· Sample Replication 
 
Many large pharmaceutical companies possess compound stores, which comprise 100,000 
to 500,000 structurally distinct samples (Devlin 1997). These compounds stored as dry 
material in individual bottles need to be formulated in a proper manner. Figure 1.4 shows a 
typical preparation methodology for HTS.  Firstly, the compounds are retrieved from 
compound store. Then, those compounds are solubilized in ‘mother’ mirowell plates. Before 
transport into screening devices, the mother plate sets are replicated into several ‘daughter’ 
plate sets. The preparation of multiple daughter copies permits compounds to be submitted 
to multiple screens and allows conservation of compound collection. 
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Figure 1.4 A common procedures for sample preparation from compound collection for 
HTS. 
 
In 2008, a prototype of fully automated laboratory robotic system proposed by Saitoh & 
Yoshimori consists of liquid handling system, parameter control of temperature and volume 
etc., and analytical HPLC (Saitoh & Yoshimori 2008). Unlike the other automated systems, 
the software modular of sample management and scheduling is added into the system. In this 
way, the time of whole experimental process is significantly reduced by running different 
tasks in parallel. 
 
1.2.6.3 Precipitation 
Precipitation has been developed as a method for protein purification and recovery. 
Precipitation has the advantages of being relatively fast and low cost. It also has simplicity 
of operation and proven track record in large-scale blood product fractionation (Curling 
1980).  
The experiment setup for USD precipitation usually involves LHS, microwell plate, shaker, 
incubator, microwell plate reader for UV absorption, and HPLC. After sample preparation 
step is completed by mixing feedstock solution with buffer solution at various ion strengths 
and pH values, the concentrations of product and impurities are then measured by either 
plate reader or HPLC. 
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Several challenges were risen up when using precipitation for industrial scale antibody 
purification. Currently, the development methods of precipitation are highly empirical 
(Niktari et al. 1990; Habib et al. 2000). Several parameters such as precipitant type, 
temperature, pH, and ionic strength can significantly impact precipitation outcomes. 
Therefore, large amount of experiments need to be executed in order to establish an 
empirical mathematical model (Knevelman et al. 2010). High throughput automated system 
is well suited for precipitation studies. The combination of microwell plates and liquid 
handling system was proved to largely improve the efficiency of research process. For 
example, the optimal condition of antibody precipitation using PEG on Tecan liquid 
handling system was reported (Knevelman et al. 2010). 
 
1.2.6.4 Chromatography 
Chromatographic processes are widely used in industrial purification process in the 
biotechnological sector. The performance of a chromatographic separation is naturally 
influenced by a various parameters e.g. salt concentration, pH and matrix etc. 
(Titchener-Hooker et al. 2008). The screening studies of high throughput chromatography 
mainly lie on ligand screening, resin screening, and column screening. 
In order to test a large amount of experimental settings by microwell plate in parallel, several 
approaches have been developed: (1) the microlitter batch incubation approach; (2) 
micropipette chromatography tips; and (3) miniature packed columns (Chhatre & 
Titchener-Hooker 2009). Common procedures in these approaches are summarized below:  
(1) applying samples to micro device;  
(2) determining the parameters through micro scale work (resin type, binding capacity, flow 
rate range, etc.);  
(3) executing further experiments to test the optimal conditions;  
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(4) evaluating the result generated from laboratory studies by pilot scale studies.  
The microlitter batch incubation approach is to use microwell filter plates where a 
well-defined volume of matrix is loaded into each well in the form of plaques or slurries of 
resin (Bergander et al. 2008). Buffer conditions for binding and elution between proteins and 
resins can be added followed by incubation, mixing, sample preparation and data analysis. 
This microwell filter plates have been proven to be successful in investigation of many 
buffers, pH values, concentrations and matrix types simultaneously. 
The second approach uses packed chromatography pipette tips to form micro columns. The 
detailed design of the tips is shown in Figure 1.5. The resin shown in grey at the base of tip is 
constrained between two screens, whilst the adaptor on a robotic pipetting arm is connected 
to the tip and thus enables the pump to draw liquid through the end of the tip before 
dispensing it back into the well (Chhatre & Titchener-Hooker 2009). The tips enable the 
liquid handling system to investigate the whole chromatography processes. Several studies 
used micropipette chromatography tips to model the performance of column (Coffman et al. 
2008; Chhatre et al. 2009; Chhatre et al. 2010).   
 
Figure 1.5 Illustration of how the tips are operated with a robotic system. 
 
The third approach is to apply miniature columns. Compared with the tips or filter plates, the 
miniature column is more geometrically similar to the large scale columns. The miniature 
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columns can be used by either hand or robot (Wiendahl et al. 2008). As shown in Figure 1.6, 
a micro column is capable of directly attached to pipetting tip of robotic LHS. The flow rate 
can be concisely controlled by the LHS. It is also reported it is very efficient when studying 
breakthrough curve and other performance parameters of chromatography.  
 
 
 
Figure 1.6 Schematic drawing of LHS compatible micro column (Wiendahl et al. 2008).  
  
In conclusion, the automated laboratory equipment has been developed for decades. The 
applications of automated approaches in bioprocess development have been reported for 
many unit operations in bioprocessing. The obvious advantage of these automated 
approaches is the high throughput experimentation capability. However  issues in the 
automated systems still exist. The prediction model generated from microscale experiments 
may not be able to fully mimic the outcome of large scale situation (Micheletti & Lye 2006). 
For example, in micro scale fermentation studies, the growth curve behaves differently 
comparing with large-scale performance due to oxygen limitation.  
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Furthermore, new challenges come with such an approach. Since the liquid handling system 
is capable of carrying out 96 or 384 experiments in parallel by benefiting from microscale 
experimentation technology, the burden on sample data analysis has increased hugely which 
requires long time and large quantity of reagents for biological assays.  
 
1.3 Data analysis methods for bioprocess development 
The applications of automated systems for experiment implementation have demonstrated 
that these devices are able to perform the experimental procedures and assays automatically 
for bioprocess development. Then data analysis is the key step in bioprocess design after 
experimentation and assay, because a large amount of experimental data can be generated 
from the automated experimentation. Data analysis includes: 1) to convert raw data from the 
measurement instruments into biological parameters; 2) to understand the process 
performance based on the data and, more important, 3) to design the new experiments for 
process development. The methods involved in these tasks will be reviewed next. 
The automated and high throughput approaches are not able to release full potential without 
intelligent experiment design and data analysis methods. In fact, the data storage and 
processing functionalities are playing an even more important role and considered as 
advances on laboratory automation (King et al. 2004). There are three types of data analysis 
tasks: 
1. To convert raw data from the measurement instruments into biological parameters. For 
example, in protein quantification using UV spectrophotometry the spectrophotometry data 
need to be translated into protein concentrations using calibration models. The software 
applications in most instruments include data analysis modules for data treatment. For 
instance, the algorithms in ChemStation (Agilent Technologies, California, USA), which 
supports the Agile HPLC instrument, can intelligently recognize the peaks and calculate the 
areas.  
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2. To store laboratory and experiment related data into the information management 
system. A system that stores and manages experiment related data is required for 
management of users, samples, and automated devices etc. For instance, the database stores 
all historical experiment design and outcome data in order to accumulate data and 
knowledge to guide future experiments on bioprocess development. 
3. To understand the process performance based on the data and, more importantly, to 
design the new experiments for process development. Here we use experiment design to 
refer to determining the experimental conditions, not the experimental procedure. For 
instance, there are sophisticated data analysis software applications capable of the design 
and analysis of experiments such as Design-Expert from Stat-Ease Software (Minneapolis, 
MN).  
As mentioned before, first type of tasks has been solved by software from automated device 
suppliers. Therefore, this sector will focus on the other two types of tasks. 
 
1.3.1 Data storage and management 
At present, most software for laboratory data storage and management comes under the 
heading of ‘laboratory information management system’ (LIMS). A LIMS is a software 
system used in laboratories for integrating all laboratory software, instruments, and the 
management of samples, laboratory users, standards and other laboratory functions such as 
sample planning, plate management, and workflow automation. In short, LIMS provide a 
solution to track, analyse, and store the data and metadata produced through the whole lab 
experimentation. Some LIMSs even provide direct integration of devices and the use of 
web-based systems in order to minimize installation and maintenance costs (Thurow et al. 
2004). However, the LIMS is usually designed for data storage and operations other than for 
direct interrelation with physical devices. 
In a laboratory, stand-alone devices are often used where a whole process study is separated 
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into individual steps such as preparation, reaction, assay, etc. This resulted in 
nonhomogeneous system landscapes with more or less autonomous automation cells. LIMS 
tries to tackle the problem by consolidate all the data into one system. However, in most 
cases, it is relatively difficult to automatically retrieve the data from different laboratory 
devices. Usually, manufacturers of experiment devices provide specific software managing 
one or more involved devices. Since no standardized interface has been defined for different 
hardware and software so far, it will apparently increase the installation cost when trying to 
integrate devices from different manufacturers to implement LIMS. Besides, since no 
sophisticated data analysis functionality coming with LIMS, the bottleneck still exists in 
processing experimental data especially when integrating with high throughput approaches. 
 
1.3.2 Experiment design and selection methods 
Beside data storage, the very first task of data analysis is to design experiments, i.e. to select 
different experiment conditions for characterizing or modelling a process. The simplest 
method is the brute-force method if neither material cost nor time consuming is considered 
as constrains. The method here is simply to test every possible experimental condition. 
While the brute-force method is simple to implement and will always find a solution if it 
exists, its cost has positive linear relation with the number of possible experiment conditions, 
which in many practical cases tends to grow very quickly when the number of input 
parameters increases. However, at early stage of bioprocess development, biological 
material is not readily available for large number of experimental investigation. Even with 
micro scale approaches, information rich experiments design is still necessary not merely to 
reduce experimental cost but to generate more accurate and reliable prediction model for 
bioprocess development. The common experiment selection methods are random selection, 
factorial selection and methods in active learning. 
Random design or random selection means to randomly generate a given number of 
experiments within the constraints of experimental inputs. For example, in some search 
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algorithms, experiment results generated from a given number of randomly selected initial 
experiments can often provide some directional information for future investigation. 
However, due to the nature of search algorithms, random selection of initial experiments 
may result in a local optimal rather than a global optimal point. Besides, it is relatively hard 
to gain any information about the relation among inputs and outputs parameters, i.e. 
response surface profile. 
The factorial selection is suitable for the experiment whose design consists of two or more 
factors, each with discrete possible values or “levels”. The factors, however, can be either 
continuous or discrete variables. The factorial selection is to select the experiments on all 
possible combinations of these levels across all such factors. Such selected experiments 
allow studying the effect of each factor on the response variables, as well as the effect of 
interactions between factors on the response variables. The method is commonly used in 
DoE (Design of Experiments). 
Another type of experiment design is ‘active learning’. Unlike traditional machine learning 
methods, active learner is allowed to choose the data from which it learns so that it performs 
better with less training (Settles 2010). The incentive behind active learning is to reduce the 
number of experiments because, sometime, it is difficult, time-consuming, or expensive to 
obtain labelled instances. For instance, in bioprocess development, the experiment results 
(label) for a set of condition variables (instances) is not easy to obtain due to high material 
cost and long processing time. Thus, it may be a promising experiment selecting tool for 
rapid bioprocess design, which is to locate the optimal condition settings by requiring a 
small number of experiments.  
One of the active learning methods is the membership query synthesis. The algorithm selects 
the experiments based on a given model. The model is then refined according to the results 
of these experiments (Angluin 1988). Different from other sampling methods, this approach 
generates instances (experiment design) by itself rather than using real world unlabelled 
instances (historical experimental results). The heuristic of active learning is as follows 
(Figure 1.7): 
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1. Start with a pool of unlabeled data (Figure 1.7(1)); 
2. Pick a few points at random and get their labels (Figure 1.7(2)); 
3. Repeat the following: 
a. Fit a classifier to the labels seen so far (Figure 1.7(3), Figure 1.7(5)) 
b. Pick the best unlabeled point to get a label for closest to the boundary (Figure 
1.7(4), Figure 1.7(6)) 
In this case, the accurate classifier has been trained without labelling all points in data set. 
 
Figure 1.7 A classification algorithm illustrating active learning concept 
 
The first prototype of robot scientist (Whelan et al. 2004) actually implemented the concept 
of membership query synthesis. The system can execute a series of autonomous biological 
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experiments to discover metabolic pathways in the yeast Saccharomyces cerevisiae. Here, 
an instance is a mixture of chemical solutions that constitute a growth medium, as well as a 
particular yeast mutant. A label, then, is whether or not the mutant thrived in the growth 
medium. The experiments are automatically designed using an active learning approach 
based on inductive logic programming. And those experiments are then carried out by a 
laboratory robot. The system model & knowledge base, active learning methods and 
automated robot together released closed-learning as shown in Figure 1.8.  
 
 
Figure 1.8 Hypothesis-driven closed-loop learning of prototype robot scientist "Adam" 
(King et al. 2004) 
 
As mentioned before, the overall cost of experimentation could be a significant factor in 
bioprocess development. Studies of active learning have taken the cost of training an 
accurate model (e.g. experimental cost) into consideration. For example, in Figure 1.7, the 
point is chosen based on not only the distance to boundary but also the cost to label it. The 
main problems researchers faced are (1) to estimate the overall cost, and (2) to minimize the 
cost that has been estimated. In the scenario of scientific discovery, it is usually difficult to 
know how many further steps that are needed to finally achieve the conclusion as well as the 
exact cost of each step. Settles (Settles & Craven 2008) proposed a novel approach to 
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cost-sensitive active learning in settings where annotation costs are variable and not known. 
The cost here is a function of time it may take to perform a query. Another successful 
example of experimental design to minimize the cost is the robot scientist Adam (King et al. 
2004). It will estimate the probability of each hypothesis being correct and to calculate the 
time and cost it may take to verify each hypothesis. A mathematical model is then 
established to deal with the trade off between the cost and the time to generate the optimal 
design. The method results in a three-fold decrease in the cost of experiment materials 
compared to naively running the least expensive experiment, and a 100-fold decrease in cost 
compared to randomly generated experiments.  
 
1.3.3 Experiment data analysis and modelling methods 
Experimental data analysis and modeling methods have been established to investigate the 
appropriate operating conditions for complex bioprocess understanding. Most methods in 
the literature are either model-based or direct process optimization (Susanto et al. 2009). 
These methods usually have sequential or cyclical nature.  
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Figure 1.9 (1) Sequential approaches of experiments design for direct process optimization, 
(2) Sequential approaches for model-based design of experiments (Franceschini & 
Macchietto 2008) 
 
1.3.3.1 Direct process optimization 
Direct process optimization is a group of methods that uses search algorithms to find an 
optimal operating condition with specified properties. The search algorithms fall into three 
classes according to the collections to be searched: virtual search spaces, sub-structures 
search of a given structure, and quantum computers (Knuth 1973). Virtual spaces search is to 
find a variable assignment that will maximize or minimize a cost function of those variables 
as well as satisfying specific mathematical equality and inequality constraints. The sub 
structures search of a given structure is to find a specific sub-structure of a given discrete 
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structure, e.g. list, tree, graph, etc. There are also search algorithms that are designed for 
quantum computers. Currently, only the virtual spaces search algorithms are adapted in the 
optimization problems of bioprocess development. When it is not necessary to investigate 
the profile of whole experimental space, search algorithms are often preferable to other 
learning techniques.  
Simplex search algorithm is a simple optimization algorithm seeking the vector of 
parameters corresponding to the global extreme (maximum or minimum) of any 
n-dimensional function searching through the parameter space (Olsson & Nelson 1975). The 
idea of simplex algorithm is to iteratively discover the n-dimensional response surface by 
changing the initial simplex, which is generated from n+1 points on the surface. Figure 1.10 
gives a simple example of simplex search algorithm on 2-dimension space. Start with initial 
‘simplex’ (ΔBWG), the algorithm will iteratively construct new simplex using the points 
from Refection (R), Contraction (C), Expansion (E), or Shrinkage (S, M). The algorithm 
will be explained in Chapter 3.  
 
 
Figure 1.10 An example of simplex search algorithm running on 2-dimension space 
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The early application that implemented simplex algorithm into bioprocess development is to 
use the algorithm to discover the optimal chromatography conditions to separate different 
components inside the HPLC system (Ghodbane & Guiochon 1988). This study actually 
combined both factorial design and simplex search optimization. Simplex search algorithm 
was firstly used to locate the optimal condition in small number of iterations. Then a full 
factorial design was conducted to understand the response surface around the optimal 
condition. However, there are some certain disadvantages of simplex algorithm (Horstkotte 
et al. 2010). Firstly, the performance of the algorithm largely depends on the selection of 
initial points. The algorithm might fail to find the global optimal solution when more than 
one extreme point are presented in the response surface, which means that the iteration 
might result in local optimal rather than global one.  
Another type of algorithms that are widely used is metaheuristic methods. The widely 
known algorithms within the class are simulated annealing, tabu search and EA 
(evolutionary algorithm). While normal heuristics are problem-dependent techniques, 
metaheuristics are problem independent, which means they do not take advantage of any 
specificity of the problem and, therefore, can be used as black boxes (Duran et al. 2009).  
These techniques usually have very good performance dealing with NP-hard 
(Non-deterministic Polynomial-time hard) problems, However, similar with traditional 
heuristic methods, metaheuristics do not guarantee that a globally optimal solution can be 
found on some class of problems (Olafsson 2006). And these methods usually implement 
some form of stochastic optimization, so that random variables generated can be crucial for 
final results for some cases (Olafsson 2006). 
The applications of these algorithms in the field of bioprocess development majorly focus 
on process scheduling and planning because these methods are powerful when dealing with 
discrete optimization problem. For example, the algorithms has been used to search optimal 
solutions for various biomanufacturing process economics model (Allmendinger et al. 
2014). In addition, some applications on chromatography optimization are reported. Among 
all bioprocess unit operations, chromatography requires large initial fixed capital investment 
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and is lack of flexibility. Many studies used the algorithms to find optimal sizing strategies 
for the sequence of chromatography steps employed to purify biopharmaceuticals 
(Allmendinger et al. 2014).  
An application of EA in chromatographic phase systems was to optimize the buffer 
composition in the capture step for a binary protein mixture of lysozym and cytochrome and 
the multi-linear gradient elution for the separation of a ternary mixture of ribonuclease, 
cytochrome, and lysozyme (Susanto et al. 2009). The research proposed a closed-loop 
optimization strategy that integrates data storage in Excel, data analysis by EA in Matlab, 
and automated devices of Tecan Evoware as shown in Figure 1.11. The research provides an 
approach to enhance efficiency of laboratory automation devices by advanced data analysis 
algorithm. However, since the structure of the whole system is designed especially for 
chromatographic phase optimization, the architecture is not capable for general use. It is also 
lack of integration with large data storage and other devices apart from Tecan Evoware.  
 
Figure 1.11 Structure of the applied optimization tool and data exchange between the 
software elements for optimization of chromatographic phase systems (Susanto et al. 2009) 
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1.3.3.2 Modelling methods 
Comparing with direct process optimization, the model-based methods are aiming to fetch 
more information about mathematical relation among all input and output variables. The 
methods can start with either a well-defined model or a polynomial equation, to estimate the 
best set of parameters that fits the experiment data.  
The most traditional statistical methods fail into the category of model-based methods. The 
aim of statistical methods is to investigate causality and to draw a conclusion on the effect of 
changes in the values of predictors on dependent variables. These methods are efficient 
especially when the relations between responses and dependent variables are known, such as 
regression methods on coefficient estimate. DoE method falls into this category.    
The technique of DoE is often used to plan experiments. The idea of DoE is to use statistics 
model to determine the significant factors as well as to estimate corresponding coefficients. 
ANOVA (analysis of variance) is widely used in DoE. ANOVA is a particular form of 
statistical hypothesis test of whether or not the means of several groups are equal, and 
therefore generalizes the t-test to more than two groups. At same time, ANOVA can provide 
a linear model with coefficient estimates and standard errors.  
The fundamental technique is a partitioning of the total sum of squares (SS) into components 
related to the effects used in the model. For example, the model for a simplified ANOVA 
with one type of treatment at different levels (one-way ANOVA). 
!!"#$%& = !!())#) + !!")+%$,+-$. 
And F-test statistic can be calculated for comparing the factors of the total deviation. 
/ = 0!")+%$,+-$.0!())#) = !!")+%$,+-$/(3 − 1)!!())#)/(7" − 3)  
where MS is mean squire, I is number of treatments, 7" is total number of cases. And the 
null hypothesis for F-test is: 
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89:	<9 = 	<= = ⋯ = <? 
where <@ is mean of ith treatment. 
If 89 is rejected from F-test, the treatment is proved to be significant factor under chosen 
confidence level. 
However, the experimental design is done to ensure that a particular series of experiments 
will be statistically capable of answering the given question, rather than to minimize the 
actual cost of the experiments. However, the biochemical material could be quite expensive, 
which results in the experimental cost being a relatively significant factor that must be taken 
into consideration during experimental design. Besides, the polynomial regression model 
generated by DoE may result in unsatisfactory fitting on complex non-linear system. 
Artificial neural network (ANN) is becoming popular in many research fields including 
bioprocess development. Instead of giving an exact mathematical expression, the alternative 
approach is to establish an artificial neural network inspired by the biological neural 
network. The central idea is to extract linear combinations of the inputs as derived features, 
then model the target as a nonlinear function of these features. The network consists of 
several linked layers, which are input layer, output layer and several hidden layers (Lek et al. 
1996). Each layer has a certain number of neurons (node). Each node in hidden layer has an 
activation function, which can be either sigmoid function or tanh function. It takes output 
values from linked nodes in previous layer as inputs, and generates output value based on 
activation function. The activation function of output node can be either sigmoid function or 
linear function depending on whether it is a classification or regression problem. In this case, 
the model generated from ANN is no longer linear combination of input factors. The 
complex multi-layer structure enables ANN to learn rather complicated non-linear relation 
between input factors and output value. 
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Figure 1.12 an example of three-layer ANN with 5 input factors and one output. 
 
There are a few of successful ANN applications for modelling the biochemical systems, 
especially the solubility studies (Eslamimanesh et al. 2011; Huuskonen et al. 1997; Zhang et 
al. 2004). The most attractiveness of this method is that it can capture the patterns of data 
precisely without knowing the mathematical relations previously. However, the method may 
be too sensitive to conclude even the errors into the final model. So the parameters including 
starting values, number of layers and learning rate should be carefully chosen before 
execution of the method.   
 
1.4 Quality assurance for laboratory automation systems 
The fault detection and quality assurance are a very import aspect in fully automated 
solutions, especially for laboratory automation. Because majority of USD experiments are 
currently carried out in mircowell plate on LHS, fault detection and quality assurance on 
LHS have drawn most attention in laboratory automation (Felton 2003).  
A few techniques have been developed to build a reliable fault detection system on LHS. 
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These are some common technologies used in LHS for fault detection. 
• Confirmation of tip mounting: A feedback sensor on each liquid handling channel to 
monitor the presence or absence of a disposable tip mounted on the cone. 
• Plate grip sensing: A feedback sensor system on robotic arm to confirm that 
microwell plate has been griped. 
• Liquid level detection: A sensor system to detect liquid level in micro well based on 
liquid conductivity and/or pressure . 
• Safe pathways: A route planning algorithm for liquid handler to make sure tips never 
travel over a sample or other piece of labware in order to reduce the risk of cross 
contamination. 
Although fault detection is a built in function for most modern LHS, quality assurance is still 
needed to reduce inaccuracy and imprecision of experiment results. Broadly speaking, the 
quality of biochemical experiment results depends on two factors: 1) the assay variability, 
and 2) the product concentration (Hentz & Knaide 2014). In turn, the sample concentration 
in the assay depends on many factors, such as initial concentration of the stock solution, 
sample storage, handling throughout the process, solubility and stability of the sample in 
medium buffer, and pipetting accuracy and dilution scheme (Popa-Burke et al. 2009). 
Therefore, assessment of LHS performance has become important in order to minimize 
experimental error occurred in automated high throughput experimentation (Taylor et al. 
2002). One of most important indicator in evaluating the performance of LHS is accuracy, 
which is commonly reported as %bias (Rose 1999). 
%BCDE = 100	×(H, − H$H$ ) 
where H,  is the measured volume and H$  is the desired volume. %bias represents the 
deviation from the desired volume, and 0% means no deviation. 
Reproducibility is measured by precision, which is calculated from the mean and standard 
deviation (SD) of a set of measurements. It is usually reported as percent coefficient of 
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variation (%CV). 
%IH = 100	×	 !JKLD7 
There are several ways for volume verification. Because a modern LHS is usually equipped 
with capacity of liquid level detection, liquid volume can be measured by calculation based 
on microwell plate dimensions and liquid level in mircowell. However, gravimetric 
measurements have been used extensively to calibrate the liquid dispensers in LHS 
(Bergsdorf et al. 2006; Rhode et al. 2004). It utilizes the mass and the density of solution to 
determine the volume. Usually, the liquid is dispensed into a pre-weighed microwell plate, 
which is weighed immediately after dispensing to prevent evaporation (Taylor et al. 2002). 
Some studies applied photometric methods, such as absorbance and fluorescence, for 
volume measurement as well (Chai et al. 2013). A study has shown that the performances of 
absorbance and fluorescence have no significant difference on determining the precision of 
liquid handlers (Petersen & Nguyen 2005). 
It is commonly accepted that a LHS is required is have a %bias value below 5% and a %CV 
below 10% (Chai et al. 2013).  
The outlier detection is another import factor to be considered in a fully automation solution. 
Because outlier detection in bioprocess experiments normally only involves 
one-dimensional data (e.g. protein concentrations), the simple way to identify potential 
outliers is to mark any points that are more than two standard deviation from mean value. 
However, the presence of outliers is likely to have a strong effect on the mean and the 
standard deviation, which makes this approach unreliable. MAD (median absolute 
deviation) is considered better method for outlier detection (Popa-Burke et al. 2009). MAD 
is a measure of statistical dispersion, and it is more resilient to outliers in a data set than the 
standard deviation. To calculate MAD of n observations,	{N=, NP, … , N-}: 
1. Calculate J@ = |N@ − KLT|, where KLT is median of {N=, NP, … , N-}. 
2. 0UJ = KLTCD7(J=, JP, … , J-) 
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Normally, observation farther than 4.5MAD from the median are marked to be outlier 
(Popa-Burke et al. 2009). Since the standard deviation of a normal distribution is 1.5 times 
the MAD (Pereira & Williams 2007), the cutoff is three standard deviations from the mean, 
where only 0.3% population will lie here for a normal distribution. The observations this far 
away can be reliably called outliers. 
 
1.5 Multi-agent based architecture for system integration 
Due to the complexity of the dynamic automation system and the demanding of a 
closed-loop learning performance, a sophisticated architecture is required. Agent-based 
techniques are considered to be suitable to accommodate the integration of the current 
independent components (Sycara 1998). Within the agent-based architecture, an agent is 
defined as an autonomous unit capable of executing actions in this environment to meet 
specific objectives (Wooldridge & Jennings 1995). An intelligent agent (IA) is an 
autonomous entity, which observes and acts upon an environment and directs its activity 
towards achieving goals. Intelligent agents may also learn or use knowledge to achieve their 
goals. They are able to corporate to accomplish a complex task in a distributed way by the 
capability of interaction and communication. The diagram shown in Figure 1.13 illustrates 
the basic principle of an intelligent agent. There is a closed learning loop inside each agent. 
The learning loop consists of two key elements: learning element and performance element. 
Agents can obtain information from the outside environment. The learning loop gains new 
knowledge according to the experiments executed by performance element. According to 
the knowledge base inside the agent, it will take actions according to the environmental 
information.  
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Figure 1.13 An intelligent agent with learning function. 
 
The agent-based architecture has shown its advantages in several diverse engineering areas 
including problem solving, simulation, collective robot etc. (Ferber & Drogoul 1992). 
Compared with traditional integration approaches, an agent-based architecture has a number 
of advantages satisfying the requirements of the intelligent automation systems. Using 
agent-based techniques, the modular approach can be adopted for biopharmaceutical 
process design because it is easier and less costly for system software modification when 
adding or deleting components (Gao et al. 2010; Genesereth & Ketchpel 1994). An 
agent-based architecture can divide complex tasks into small and manageable sub-problems 
(Sycara 1998). The agents can collaborate to solve the presented problem by communication 
and interaction with each other so the simultaneous facilitation of information exchange is 
feasible. Based on these features, the agent-based architecture provides an ideal approach to 
integrate all the components involved in the required closed-loop learning. For example, the 
design algorithm, experiment execution and assay may each be regarded as an autonomous 
agent to perform defined tasks. The flexibility of the architecture makes it easy to add new 
algorithms and devices into the platform without significant modification of architecture 
software.  
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Although there are few publications on applications of multi-agent system for bioprocess 
design and optimization (Gao et al. 2010), the architecture has been successfully 
implemented in the mechanical manufacturing optimization (Chen & Chen 2010; Maturana 
& Norrie 1996). Different from traditional manufacture system for mass production, the 
flexible manufacture is becoming preferable to survive the vicissitude of the market.  So the 
production process and schedule need to be re-designed frequently. Due to the large scale of 
the production process, multi-agent architecture is regarded as the best solution: each agent 
represents a specific machine or procedure and the best design can thus be achieved through 
the auction mechanism of agents. Traditionally in bioprocess development, each unit 
operation is studied separately, which makes it difficult to capture interactions among unit 
operations. However, multi-agent based approach can overcome this problem to potentially 
provide a global optimal solution (Gao et al. 2010). A framework of multi-agent system may 
be developed to handle the optimization of bioprocess, in which each agent consists of 
knowledge base and learning module for a specific bioprocess operation, and agents 
cooperate to find the optimal design according to the design requirement (purity, yield etc.).  
 
1.5 Conclusions  
The wide implementation of microscale devices and equipment enables a new way of doing 
experiments with extremely small volumes. In this way, the cost of materials would be 
significantly decreased and at the same time, large number of experiments can be executed 
in parallel.   
The automated instruments have been introduced into the bioprocess development for many 
years. The liquid handling systems are liberating researchers from simple and repeatable 
liquid transfer tasks. In addition, the errors that generated by researchers during performing 
these tasks can be avoided. The total automated laboratory system enables even more 
experimental tasks to be done automatically. 
The software applications, which came along with the automated instruments, have shown 
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their power in many bioprocess development cases. The software developed by Tecan such 
as EVOware and FACTS are capable of controlling several different devices within a single 
software environment. These two software applications make it possible to add scheduling 
features while executing experiments so as to better utilize all the instruments. The 
laboratory information management system can store and analysis the data generated from 
different instruments. 
All these advanced technologies are currently used in development of bioprocess. However, 
researchers tend to use them separately so as an experiment usually involves several 
instruments and software. Therefore, the following disadvantages would appear. 
• Simple and repeatable manual work is still required such as liquid handling, simple 
calculation of pH, volume, instrument configuration etc. 
• Experimental data sometimes is difficult for researchers to organize and analysis 
because those can be generated from different experiments.   
• Instruments may have conflicts on scheduling, e.g. one instrument can be extremely 
busy at one time period while the others may be idle when there are more than one 
experiments being executed. 
• Laboratory logistics can be unnecessarily increased due to frequent transfer of 
experimental materials among different instruments, which are usually located in 
different locations. 
Although there is no such a prototype that can perform entire closed-loop learning tasks on 
bioprocess development, each part of the learning loop such as automated instruments, 
laboratory information management system, and data analysis and modelling methods has 
been well developed for several decades. Therefore, a software that integrates both 
laboratory automation device and modern data analysis techniques may be feasible and can 
potentially speed up bioprocess development significantly. 
Thus, an efficient and cost-effective system for automated bioprocess development is 
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extremely important and desirable. The system should bring all the elements operated 
manually into an automated platform. This includes the physical devices that carry out 
experiment preparation, experiment execution and assays. In other words, the system should 
consist of five types of software:  
1) Software to drive each device timely;  
2) Software to consolidate the data for each device due to their different format;  
3) Software of sequential design algorithms that realize the process design objectives 
and capable of process evaluation, prediction and optimization;  
4) A database used for storing the experimental data and information of instrument 
configurations;  
5) Software to control and manage above software. 
My research project aims to develop and evaluate such an intelligent automation platform 
for bioprocess development (IAPBD). Firstly, a feasible architecture is required for 
integration of both physical devices and data analysis. The architecture should be capable of 
controlling liquid handling system, plate shaker, plate reader and other assay devices. 
Besides, the effective communication mechanism will be presented to integrate automated 
hardware devices with data storage and analysis modules. Secondly, a group of agents will 
be designed to deliver tasks in experiment design, experiment execution, assay, data analysis 
and etc. Thirdly, a series of representative bioprocess development case studies will be 
performed using the platform. The case studies will cover both upstream and downstream 
bioprocess unit operations. The purposes of the case studies is to examine whether a 
intelligent bioprocess design platform including experiment design, execution and 
sequential analysis algorithms can be automated; to evaluate the capability of the platform in 
solving practical bioprocess development problems.  
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Chapter 2 Intelligent Automation Platform for Bioprocess Development 
(IAPBD) 
 
2.1 Introduction 
The applications of mircoscale bioprocessing studies have covered all major unit operations 
ranging from upstream and downstream. The wide implementation of these microscale 
bioprocessing techniques offers the potential to speed up bioprocess design, reduce research 
and development cost and shorten delivery time of new drugs to the market. The application 
of robotic automated devices enables even faster bioprocess development by significantly 
reducing the experimentation time and eliminating errors from manual operations. These 
automated approaches are reported to be capable of speeding up the acquisition of process 
information (Micheletti & Lye 2006; Jackson et al. 2006). 
However, it is also reported that biopharmaceutical development is becoming more time 
consuming and expensive due to the difficulties in bioprocess design and optimization. The 
drug molecules are getting more complex and requiring more experiments to characterize 
their properties. With the automated platform, a much larger design space could be explored 
to discover much better solutions, which leads to the increase of the experiments (Karlsson 
et al. 2004). The automated platform can deal with the substantial increase in the 
experiments well via parallel or high throughput experimentation at micro scale. However 
the data analysis burden can be handed by some of the high throughput analytical 
instruments but a large portion of biological analysis is not high throughput compatible. On 
the other hand, the volume of the data generated has also substantially increased. To treat 
these raw data and make sense out of the data efficiently require large amount of time. The 
volume, complexity and diversity of the data sets have made data analysis the new 
bottleneck for the process development. A few techniques have been implemented in 
bioprocess design and optimization such as statistical modelling, search algorithms and 
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metaheuristic methods. However these methods and their software are isolated from 
automated experimentation devices so the data processing and analysis are labour intensive 
hence slow down the process design. 
In this chapter, an intelligent automation platform for bioprocess development (IAPBD) has 
been proposed to address the data processing and analysis problems in micro scale 
experimentation. IAPBD aims to automatically perform the experiments and data analysis 
without the involvement of manual operations. This novel approach of laboratory 
automation integrates the currently independent parts, the experiment design, experiment 
execution and assay analysis together to allow bioprocess solutions to be investigated 
rapidly within the automated platform. 
In this chapter, I have created software that realizes IAPBD’s functions. The concept of 
IAPBD design is presented in section 2.2.1. The detailed design for each element in IAPBD 
is given in Section 2.3 after the introduction of relevant background and terminologies in 
Section 2.2.2. 
 
2.2 Conceptual design of the intelligent automation platform for bioprocess 
development (IABPD) 
2.2.1 A closed-loop learning framework 
When exploring a large design space, the sheer volume of experiments needed is 
substantial. In a fermentation process, more than 20 variables in medium design and 
process operations need to be characterized. In chromatography process, to characterize 
several resins compound with their buffer conditions for load, elution and equilibrium 
require a huge amount of experiments. If whole bioprocess design approach is considered, 
the interactions between steps also need to be investigated, then the demand on 
experimentation will be very high. 
As reviewed in Chapter 1 the search methods are preferred as such approaches start with a 
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small set of experiments to get knowledge of the biological material properties and key 
process performance parameters. Based on the feedback from the gained knowledge new 
experiments are then designed iteratively to achieve their process development goal. Such 
approaches, if used manually, are practical, manageable but often time consuming.  
The concept of the closed-loop learning has been adopted in machine learning research for 
many years (Settles 2010). The incentive behind the concept is that the current optimal 
solution can be iteratively improved by taking latest feedback into consideration. The 
implementation of the closed-loop learning in bioprocess development involves the control 
of experimentation devices and operations, data processing and decision-making on new 
experiment design. Conceptually, starting with a set of initial experiments from the user or 
database, the intelligent automation platform for bioprocess development based on the 
closed-loop learning approach intents to drive the experimentation devices to perform 
defined initial experiments and drive the analytical devices to detect the data after the 
experiments are completed. Then it will pick up the data from the analytical devices and 
perform data analysis that turns the raw data into variable values such as protein 
concentrations, and carry out process evaluation based on the design objectives. After 
evaluation of the design solutions, it will decide to stop or continue to design the next round 
experiments for further optimization. As shown in Figure 2.1, the framework of IAPBD 
consists of five different components: 1) data & knowledge base; 2) sequential design 
method; 3) execution of experiments; 4) assay execution; 5) data treatment. 
Data & Knowledge base is a database designed to store and accumulate the data of previous 
experiment results. It will have the capability of providing supporting data for experiment 
design such as operating area, input variables and output variables. 
Sequential Design Method is a software element that has the experimental design algorithms 
established, capable to design a batch of experiments compatible with micro scale devices, 
then translate the experiments into detailed simple tasks, finally write the command scripts 
for these tasks that can be recognized by experiment devices. It also performs evaluation of 
returned experiment data based on the pre-defined research objectives, makes decisions on 
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whether it is necessary to plan next batch of experiments to get further results. If the 
expected objectives have been achieved, i.e. new knowledge has been successfully 
discovered, the new knowledge will be added into knowledge base. If not, further validation 
experiments will be send to Execution of Experiments & Assay element to execute. 
Execution of Experiments & Assays are hardware associated with the experimentation to 
deliver the pre-defined tasks. IAPBD should be designed to drive this hardware at right time 
through communication. 
Data Treatment is another software element that processes raw data, translates raw data into 
the format that has biochemical meanings. For example, it translates uv absorption data into 
protein concentration. 
A key element in the closed-loop learning is the objectives of the activity, which needs to be 
defined beforehand. To deliver a process design activity, the objectives must be defined and 
formulated mathematically by the users. Typical design objectives include purity, yield, cost, 
productivity or combination of them. This will help the biochemical engineers focus on their 
goals.  
 
Data & Knowledge 
Base
Sequential Design 
Method
Execution of 
Experiments
AssaysData treatment
 
Figure 2.1 Framework of intelligent automation platform to realize the closed-loop learning 
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2.2.2 Background and terminologies in IAPBD  
Utilized artificial intelligence (AI) and objects-oriented programming (OOP) IAPBD has 
been designed to drive the framework to deliver automated bioprocess design tasks. The 
development of the intelligent automation platform involves a few of techniques in software 
engineering. Before presenting the detailed design, some of the background and 
terminologies will be introduced. 
2.2.2.1 Object oriented programming 
Object oriented programming (OOP) is a programming paradigm based on the concept of 
“objects”, which are data structures that contain data field (attributes) and methods 
(functions). An important feature of OOP is that an object’s methods can access and often 
modify the attributes of the object with which they are associated.  
The ideas behind OOP are back from a programming language called SIMULA (Nygaard 
& Dahl 1978). The language was designed for doing simulations. Moreover, it firstly 
introduced objects, classes, inheritance and subclasses, and discrete event simulation. Later 
the concept of objected-oriented has been applied in systems programming, graphics, and 
AI programming (Stefik & Bobrow 1985). Comparing with other program paradigms such 
as Procedural Programming and Functional Programming, OOP has certain advantages in 
code reusability, reliability and flexibility, and maintenance (Nierstrasz 1989). Therefore, 
OOP is chosen for development of IAPBD. 
To increase code reusability and extensibility, the notion of “class” is introduced. “Class” 
defines the data format (attributes) and available procedures (methods) for a given type of 
objects (Stefik & Bobrow 1985). “Object” inherits the definition from “class”, whose 
structure contains both attributes and methods. In other words, each object is said to be an 
instance of a particular class. For example, an object with its name attributes set to be 
“computer” might be an instance of class “Product”.  
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Another importance concept in OOP is “interface” (Stefik & Bobrow 1985). An interface 
is a common protocol for unrelated objects to communicate with each other. It is a set of 
definitions of methods and attributes, which the classes agree upon in order to cooperate. 
The design of a class is illustrated in a box containing three parts as shown in Figure 2.2A. 
The top part contains the name of the class. The middle part contains the attributes of the 
class. The bottom part contains the methods, which the class can execute. An example of a 
class diagram is shown in Figure 2.2B. A class of “bank account” has two attributes: owner 
and balance. The class has two methods: deposit and withdraw. 
 
A.  B.  
Figure 2.2 A. A class diagram containing class name, attributes and operations (methods); 
B. An example of the class diagram representing a class of “bank account” 
 
OOP has several great advantages. 1) It increases code reusability. Objects created for 
OOP can easily be reused in other programs. 2) An object has ability to hide certain parts 
of themselves from other objects, and defines how it can be interacted. This feature 
prevents various kinds of errors. For example, with OOP, the pH value in an experiment 
cannot be set beyond 14. 3OOP is easier to design and program comparing with other 
programming styles. The incentive behind OOP is experience in real world, which makes it 
easy to write and maintain  
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2.2.2.2 Entity relation model (ERM) 
An ERM is a model that uses a systematic process to describe and define a subject area of 
data. ERM was first introduced in late 1970s for unification of different views of data: the 
network model, the relational model, and the entity set model (Chen 1976). In ERM, the data 
are represented as entities that are linked with each other by relationships. The relationships 
express the dependencies and requirements between entities. Similar to OOP, the entities can 
have various attributes. ERM now is widely implemented in database design due to several 
advantages: 1) straightforward relation representation; 2) easy conversion to other data 
model; 3) graphical representation for better understanding (Chen 1976). The database that 
follows the concept of ERM is called a rational database. In this case, each table in the 
database is one instance of an entity, while each row in the table is the attributes.  
The diagram that represents ERM is called entity relationship diagram. There are a few 
different ways to draw ER diagram. A commonly used diagram is very similar to the class 
diagram as mentioned earlier in this chapter. Same as the class diagram, the entities in ER 
diagram are represented by boxes with three different parts. The top part is the name of an 
entity. The middle part is the primary attributes (primary keys), which work as indexes in 
data tables. Thus, the value of primary key (PK) must be unique in each row. The lower part 
is other normal attributes. The linkages among different entities represent the relationships. 
There are three types of those relationships: 1) one to one; 2) one to many; 3) many to many. 
The attributes who have one-to-one relationship with other table’s PK are called foreign 
keys (FK). Figure 2.3 shows an ER diagram representing the database design for experiment 
data storage in database. For an experiment, the experiment ID, the input data and output 
data need to be stored. Therefore the diagram has three entities: experiment, experiment 
design and experiment result. Because each experiment has a unique ID, three entities are 
linked by two one-to-one relationships.  
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Figure 2.3 A ER diagram representing the database design for experiment storage in 
database. 
 
There are two major advantages using the rational database based on ERM in IAPBD. 
Firstly, it reduces redundancy in database. Because relationships among different data 
entries are well defined in ERM, same sets of information is not necessarily stored in 
multiple data tables. Secondly, it is simple and easy to understand. The structure is 
descripted in business user’s language, and even non-technical user can understand easily. 
 
2.2.2.3 Application Programming Interface (API) 
An API is a set of commands as well as the format of those commands which can be sent 
by one program to another so that programs can communicate and use each other’s 
functions directly. An API defines functionalities regardless of their respective 
implementations, in which case the definitions and implementations are not necessary to 
be same. 
In laboratory automation, an API is provided by an automated device’s supplier, so that the 
third party program can use its commands to communicate with either control software or 
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the device directly. For example, EVOware is the software designed to control Tecan 
robotic LHS, and its API provides commands that allow a third party program to 
communicate with EVOware. Therefore the LHS can be controlled by a third party 
program. 
 
2.2.2.4 Extensible Markup Language (XML) 
XML is a markup language that defines a set of rules for encoding documents in a format, 
which is readable for both human and machine. XML was developed by an XML Working 
Group formed under the auspices of the World Wide Web Consortium (W3C) in 1996 (Bray 
et al. 1997). The XML is designed to transport and store data. According to design goals of 
XML, it has some advantages: 1) it is straightforwardly usable; 2) it supports a wide variety 
of applications; 3) it is easy to write programs which process XML documents; and 4) it is 
human-legible and clear. 
The basic building block of an XML document is an element, defined by tags. An element 
has a beginning and an ending tag. The XML document forms a tree structure that starts at 
the “root” element and branches to the “leaves". This structure enables XML to support 
hierarchical data structures or “nested” elements. An example of using XML to describe a 
precipitation experiment is given below: 
 
<?xml version="1.0" standalone="yes"?> 
<experiment> 
<input> 
    <salt_concentration unit=”mg/mL”>10</salt_concentration> 
<pH>7</pH> 
</input> 
<output>  
 <yield>80</yield> 
<purity>90</purity> 
</output> 
<objective_function>0.86</objective_function> 
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</experiment> 
 
In this example, the experiment has two input variables, which are salt concentration and pH 
value, two output variables, which are yield and purity, and the value of an objective 
function. All of the information has been represented in the XML format as shown in the 
example. 
 
2.3 Detailed IAPBD design  
In order to deliver the closed-loop learning in bioprocess design activities, I have designed 
the data structure and a rational database, four agents, and a multi-agent architecture to form 
the IAPBD. In the following sections, multi-agent architecture, database design as well as 
data structures will be described first. Then each of four agents will be presented 
respectively. 
 
2.3.1 Multi-agent architecture for the intelligent automation platform 
The multi-agent architecture has been proposed for my intelligent automation platform for 
bioprocess development which will be referred as the platform. The platform has four 
individual yet connected agents: Coordinate Agent, Execution Agent, Experiment Design 
Agent, and Assay Agent as shown in Figure 2.4. 
In order to control all of the software agents to accomplish a defined task, an efficient 
communication protocol is needed to link all the agents together. An interaction protocol 
that is able to support several activities such as the communication of global goals, sharing 
of knowledge, and avoidance of conflicts is essential in multi agent architecture design 
(Davidsson & Wernstedt 2002). The most widely applied interaction protocols are contract 
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net (Davis & Smith 1983), market mechanism (Wellman 1995), and blackboard (Nii 1986). 
The first two are designed to simulate real market activities on the assumption that a global 
optimum exists for the equilibrium of the market such that the “seller” wants to maximize 
profit while the “buyer” wants to maximize utility. The agents in these protocols therefore 
have similar functionalities such as “buy” and “sell.” When agents are capable of different 
functions, the architecture based on the “blackboard” mechanism is attractive. The 
blackboard is a database, which all relevant agents can access to. The agents perform tasks 
based on the information on the blackboard. The agents publish the results on the blackboard 
at real time and continuously until the goal has been achieved.  
 
 
Figure 2.4 Multi-agent architecture for the intelligent automation platform.  
 
The Coordinate Agent retrieves the historical experiment data from an ER database and 
writes the new executed experiment results into the database. It also translates the 
information in the database in the message format to blackboard. The blackboard is the place 
to publish two types of information. One is the configuration data such as platform layout, 
database connection parameters etc. The other is the experimental data. The data of each 
experiment will be published in the format similar to that stored in ER database. The 
message format in an experiment has the tree-structure stored in the XML file where the 
Execution Agent
Experiment Design Agent
Assay Agent
Blackboard
Experiment setting information
Experiments to be executed
Previous experiment results
Device configuration data
…..
Coordinate Agent
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parameters will be defined. It includes experimental number, attributes of experimental 
setting (e.g. parameters and assays) and results. An example of message on the blackboard 
for lysozyme precipitation experiment is shown in Figure 2.5. The agent selects all relevant 
experiment data both from database and other agents and displays them on blackboard. 
Other agents can access to update specific fields, e.g. experiment result, when they are 
available. 
The Execution Agent controls the liquid handling system, e.g. Tecan Freedom 200, to add the 
different reagent solutions into the microwell plates, the plate shaker to perform mixing 
related tasks, and the vacuum pump to perform separation tasks.  
The Assay Agent controls assay devices, e.g. the plate reader and HPLC. It communicates 
with the Coordinate Agent to carry out the experiments for calibration if there is insufficient 
data from Coordinate Agent. Based on the calibration results, the agent reads data from the 
assay devices and calculates the desired readings of each well.  
The Experiment Design Agent comprises machine learning algorithms. Based on these 
algorithms, the agent publishes the newly designed experiments on blackboard for execution. 
It also carries out data analysis and process evaluation. 
 
2.3.2 Database and data structure design 
2.3.2.1 ER database design 
The data and knowledgebase is designed to store three different types of information: 1) 
historical experiment data including experiment conditions, input parameters, and 
experiment result; 2) device configuration data such as layout information about different 
devices on LHS, connection parameters for the plate reader; 3) general knowledge, e.g. pH 
buffer mixture settings. The information is stored in database following ERM. A typical 
experiment involves chemical reagents, labware and automated platform configuration, 
experiment design and results. The entity-relationship model designed for the experiment in 
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the database is shown in Figure 2.5.  
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Figure 2.5 Entity-relationship model design for the database 
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2.3.2.2 Data structure of experiment 
Experiment data include inputs and outputs as well as other information such as ID. The data 
structure must be defined to allow agents to recognise them and dispose data correctly. Four 
classes are designed as shown in Figure 2.6.  
Figure 2.6(1) defines the format of experiment output variables where “name” means the 
parameter’s name and “value” means the measurement of corresponding output parameter. 
Default value is -1 means the output value has not been obtained.  
Figure 2.6(2) defines the format of input parameters where “type” means the name of input. 
The operating range of the corresponding input parameter is given by “min” and “max” 
value to define design space.  
Figure 2.6(3) defines data structure for processing experiment design information. The 
binary variable of “complete” indicates whether the experiment is finished. The parameters 
involved in the experiments are defined in attributes “inputs” and “outputs”, which are the 
lists of instances of “input” class and “output” class. The method of “read_record” is a 
function to check from database if the experiment has already been done previously. The 
method of “record” is to store the experiment result into database after the experiment has 
been completed.  
Figure 2.6(4) defines the other experiment parameters like buffer type, buffer strength, and 
platform layout.  
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+experiment()
+read_record() : bool
+record()
+complete : bool
+exp_id : int
+inputs : List
+outputs : List
experiment
+name : string
+type : string
+value : double
+max : double
+min : double
input
+name : string
+value : double = -1
output
+init_area()
+validate_exp()
+bufferstrength : double
+buffertype : string
-ID : int
+inputs : List
+outputs : List
+layout_id : int
experiment_setting
(1) (2) (3) (4)
 
Figure 2.6 Classes related to experiment.  
 
Corresponding to the class design, the ER model of the experiment in the database is 
extracted from Figure 2.5 and shown in Figure 2.7. The table of “experiment” records the 
basic configuration information. The table of “experiment design” consists of all the 
parameters involved in the experiment. The historical experiment results are stored in the 
table of “experiment result”. Each experiment is assigned with a unique globally unique 
identifier (GUID) code.  
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Figure 2.7 Tables in IAPBD’s database that related to experiment 
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2.3.2.3 Data structure of device information: LHS layout  
The robotic arm moves within a defined area in the platform to deliver tasks. A set of 
coordinates on platform has been defined to allow the robotic arm deliver tasks accurately, 
e.g. to add reagents to defined locations. There are two types of instruments and devices in 
the platform. One is “labware” like disposable tips racks, microwell plates, filter plate etc. 
The other type is called “carrier” where the labware  can be located. The locations of both 
carriers and labware is represented by tree structures. As the example shown in Figure 2.8, 
each layout of these carriers and labwares has a unique ID in the database, which acts as the 
highest level of the tree structure. Carriers are in the middle level, while labware is at the 
lowest level.  
The coordinates of the platform consist two variables, grid and site. Each grid can only be 
occupied by one carrier in a layout, however each carrier can occupy more than one grid 
dependent on the width of the carrier. The number of sites depends on the locations on a 
carrier where labware can be placed on.  
These classes in the database are then designed according to the layout structure as shown in 
Figure 2.9. Figure 2.9(1) defines the configuration parameters of the carrier: grid, width, site 
number in this carrier, and a list of labware located on the carrier. Figure 2.9(2) defines the 
configuration parameters of labware: site, type and name. Figure 2.9(3) is a list of carriers 
within the layout. The method “load_layout” is to load a layout from database by a given 
layout ID. The method of “layout_script” is to translate the layout into Tecan Script format, 
which can be recognized by Tecan LHS.  
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Layout
ID=1; purpose=precipitation
Carrier
Grid=1; name=DiTi 3Pos 
Carrier
Grid=45; name=Infinite 200 
Labware
Site=2; name=DITi 1000uL
Labware
Site=3; name=DITi 1000uL
Labware
Site=1; name=DITi 1000uL
 
Figure 2.8 An example of the layout structure with a carrier carrying three disposable tip 
racks and an Infinite 200 plate reader connected 
 
(1) (2) (3)
+carrier() : carrier
+allowed_labware() : List
+name : string
-width : int
-sites : int
-type : string
-id : int
-labwares : List
carrier
+labware() : labware
+allowed_carrier() : List
+id : int
+name : string
+type : string
labware
+load_layout()
+layout_script()
+transwelstring() : string
+getditiwastegrid() : int
+getditiwastesite() : int
+getwastegrid() : int
+getwastesite() : int
+getcleanergrid() : int
+getcleanersite() : int
-carriers : List
-id : int
layout
 
Figure 2.9 Classes related to tree-structure layout.  
 
The ER model between the carrier and labware in the database is shown in Figure 2.10. The 
tables of labware and carrier have the information of every devices and equipment in the 
system. The table of “carrier_labware_relation” stores which labware can be located on each 
carrier. 
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layout
PK,FK1 ID
 purpose
layout tree
PK carrier
PK labware
PK carrier grid
PK labware_site
PK,FK1 layout_id
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carrier
PK,FK1 ID
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 type
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PK,FK1 ID
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PK,FK2 carrier_id
PK,FK1 labware_id
 
Figure 2.10 Tables and relations for layout in the database.  
 
The data structure designed provides a way for different agents to exchange information 
efficiently so that each agent is able to translate information from blackboard into the 
formats that can be understood.  
 
2.3.3 Agent design 
2.3.3.1 Execution agent 
The Execution Agent is responsible for carrying out the experiments. Its major task is to 
manage connection between platform and laboratory devices. As discussed in previous 
chapter, API can be used for program communication. The functions can be shared by each 
other. For automated devices with API, the Execution Agent can control them directly. 
Although manufacturers provide software to control their automated devices, the APIs are 
often not included. Then it is not possible for the agent to get direct control of those devices. 
However, some software has functionalities to call a third party executable file and to take 
return data into its program during operation. This makes it possible to insert data into their 
software. Therefore, four solutions have been developed in the architecture of Execution 
Agent, shown in Figure 2.11, for the agent to connect with experiment execution devices.  
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Figure 2.11 Architecture of the Execution Agent  
 
1) The agent has full access to the devices (Device A in Figure 2.11). In this case, our 
program can directly control the devices without any problem. For example, Tecan provides 
APIs that allow the third party program to send commands directly to the Tecan LHS. Based 
on the APIs, I designed a class to compose and send operating scripts, which can be 
understood by Tecan LHS. Figure 2.12 shows the class diagram for controlling Tecan LHS. 
The commands include all the basic operations such as aspirate, dispense, drop tips, get tips 
etc. 
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+aspirate() : Script
+dispense() : Script
+drop_tips() : Script
+get_tips() : Script
+getditi() : Script
+mix() : Script
+moveVaScap() : Script
+moveVaScapBack() : Script
+ToDecimal() : Script
+transfer() : Script
+wash_tips() : Script
+wellselection_8() : string
+wellselection_96() : string
-scr : Script
operations
 
Figure 2.12 Class diagram for controlling Tecan LHS.  
 
2) The agent has no access to the devices (Device B in Figure 2.11), but the original 
controlling software allows calling the third party program during the operation. For 
example, older model of Tecan LHS controlled by software called Gemini. In this case, 
since the agent cannot command the device, a ‘translator’ is developed to pass values of 
parameters from original software to the platform. The ‘translator’ is a small program that 
will be called by the original software during the operation. As shown in Figure 2.13, 
although the agent cannot control LHS directly, a translator will be called from LHS and 
return back the information needed. 
3) The agent has no access to the device (Device C in Figure 2.11), and the original software 
has no functionalities to call third party program during operation, but the device software 
will generate some log files after operation. In this case, a program called ‘watcher’ is 
designed to monitor a pre-defined system path. Whenever there are new data generated in 
the path, the ‘watcher’ will automatically report status to the agent. 
4) The agent has no access to the device, and there is no log file generated after operation. In 
this case, the status parameters will be report to the agent manually. 
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Figure 2.13 A simple example illustrating how translator works together with Execution 
Agent to pass information into LHS during operation 
 
2.3.3.2 Experiment Design Agent 
A predefined interface has been designed for algorithms to follow as shown in Figure 2.14. 
The interface makes it very convenient to integrate IAPBD with other algorithms since no 
additional modification is needed in source code. The interface has six variables and one 
method: 1) name: this is the name of algorithm, which will be stored in database; 2) sample 
experiments: this contains experiment setting data e.g. input and output parameters, to guide 
experiment design; 3) working experiments: this shows the list of experiments currently in 
memory and being analysed in which the unfinished experiments will be published on 
blackboard for execution; 4) finish: this parameter indicates if the iteration has been finished; 
5) method: this shows the method that the algorithm employs to process and design 
experiments. This general interface is designed to allow any new algorithm to be added with 
minimum effort as long as the format is followed. 
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Figure 2.14 Interface design for experiment design algorithms.  
 
The Experiment Design Agent will communicate with other agents through publishing data 
in the blackboard. When a new set of experiments has been designed, the experiment 
conditions with data structure of experiment will be sent to blackboard. The Execution 
Agent can pick up the information to plan ahead. Once all the working experiments have 
been labelled as completed, the agent will start data analysis and process evaluation based 
on selected design method. And the agent will decide whether optimal solution has been 
achieved. If not, it will publish new set of experiments to be executed for further evaluation. 
 
2.3.3.3 Assay agent 
The Assay Agent is similar to the Execution Agent. It is responsible for managing different 
assay devices, and one of the key tasks is to retrieve the data from the devices. The 
architecture of the Assay Agent is similar to the one of the Execution Agent as shown in 
Figure 2.15. Because not all manufacturers provide API access to their analytical devices, 
the “translator” and “watcher” techniques have been used to fetch experiment results.  
Additional information may be needed to convert raw data collected (e.g. UV absorption) to 
parameter values (e.g. protein concentration). The agent is capable of publishing new 
experiments on blackboard to establish calibration of the analytical devices. After the 
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experiments have been executed on the platform, the raw data collected from these 
experiments is used to generate calibration curve for those experiments results, which are 
from Experiment Design Agent. In the case that it is not feasible to carry out calibration 
experiments on automated platform, the experiments will be executed manually before 
writing relevant calibration data into database. 
 
 
Figure 2.15 Architecture of Assay Agent 
 
2.3.3.4 Coordinate Agent 
The Coordinate Agent manages the database by retrieving historical experiment data and 
configuration data, writing new executed experiment information from blackboard into the 
database. Besides database management, the Coordinate Agent manages the information 
published on blackboard. This agent is also responsible for some calculations based on 
general background knowledge that stored in the database, e.g. calculating desired volumes 
for each solution when preparing buffer solution. 
The blackboard contains the information of experiment settings, previous results and 
automated devices configuration data. It is an information-sharing place and other agents are 
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allowed to access it, obtain new tasks and publish results on it. As illustrated in Figure 2.4, 
Execution Agent, Experiment Design Agent and Assay Agent are all communicating with 
the Blackboard. For example, when the Experiment Design Agent completes an experiment 
design, it will publish the experiment design information on the blackboard. The message is 
formatted in XML. 
A message showing an experiment published on blackboard by Experiment Design Agent is 
illustrated in Figure 2.16. From left to right, the objective function value is 0.5. The 
experiment’s objective function is defined by 0.4*a+0.6*b, where ‘a’ is the salt 
concentration and ‘b’ is the lysozyme concentration. The parameters investigated in the 
experiment are salt concentration and lysozyme concentration. The parameter consists of 
design space information (maximum & minimum values and interval) and the actual value. 
The protein involved in the experiment is lysozyme and its peak appears at 15 min when 
using HPLC to measure the concentration. 
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Figure 2.16 An example of messages on blackboard showing an experiment published by 
the Experiment Design Agent. 
 
Buffer preparation is a one of the common tasks in biological experiments. Traditionally 
when buffer solutions for different pH value is prepared before experimentation manually. 
For example, when preparing phosphate buffer solutions with various pH values, 
researchers have to check the volumes of monosodium phosphate and disodium phosphate 
solution needed from a predefined table, and then prepare each buffer solution separately 
by mixing two reagent solutions manually. However, it is not feasible in closed-loop 
learning approach. Each experiment is design dynamically by the algorithms, which means 
the pH value needed in the experiment is unknown before the experiment and changing at 
each iteration. Thus the buffer is prepared by mixing two solutions of specific volumes 
calculated in real time based on the knowledge in the database. The Coordinate Agent is 
designed to be capable of calculating desired volumes of each reagent solutions for 
Last	update	:	experiment	design			
Type:	experiment
ID
Experiment	setting
001
Objective	value 0.5
Last	update	:	coordinate	agent
Type:	experiment	setting
parameters
Objective	function 0.4a+0.6*b
proteins
Last	upadate	:	coordinate	agent
Type:	parameter
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Last	update	:	coordinate	agent
Type:	parameter
name
value
lysozyme	Conc
0.5
max 1
min 0
interval 0.1
isInput false
alias b
Last	update	:	coordinate	agent
Type:	protein
name
Retention	time
lysozyme
15
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preparing buffer solution. The calculation performed by the Coordinate Agent is shown 
below. 
If a buffer is composed of	8-UVW-	(7 = 0…X), where H is hydrion, n equals the number of 
hydrion, A is the acid radical, and N equals the total positive charge of A, its dissociation 
constant Y- is: 
Y- = H[ 8-W=U8-U 			7 = 1…X                
Y-[= = H[ 8-U8-[=U 			7 = 1…X    
...              
YV = H[ 8VW=U8VU 			7 = 1…X 
At a given value of pH, these expressions give the relative ratios of each component: 
		[8-U][8VU] = Y-[=[H[] ∗ Y-[P[H[] ∗ … ∗ YV[H[]               [8-U][8VU] = Y-[=Y-[P …YV8[ VW-  
Assume B is the buffer strength: 
_ = 8-UV-`9  
_ = 8VU 8-U8VUV-`9 = [8VU] Y-[=Y-[P …YV8[ VW-  
Thus, the actual concentrations can be obtained by following equations: 
8-U = Y-[=Y-[P …YV8[ VW- 8VU = Y-[=Y-[P …YV8[ VW- ∗ _Y-[=Y-[P …YV8[ VW-   
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8-U = _8[ VW- 18[ VW- 
For buffer solution make of 0VWa8aU and 0VW%8%U, we have: 
8[ + N ∗ X − B ∗ _ + 1 − N ∗ X − D ∗ _ = b8W + X − 7 [8-U-WV]V-`9  
where N = c#&d,+	#e	fghijik		lmnopqmr$#$%&	c#&d,+	#e	adee+)	.#&d$@#- 
Thus, the require volume of 0VWa8aU and 0VW%8%U can be calculated by solving the 
equation above. The information of buffer system (i.e. Y-) is stored in the database. The 
design of the tables and relations is shown in Figure 2.17. The system will firstly search the 
preferable buffer system in the corresponding experiment setting. If there is no preference, 
the system will give all the available buffer systems within the feasible range of pH value. 
 
chemical
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 type
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 charge
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PK,FK1 ID
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 chemcialB
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base
PK,FK1 ID
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Figure 2.17 Tables containing buffer information in the database 
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2.4 Quality assurance for IAPBD 
As a fully automated solution, quality assurance is an essential aspect for IAPBD. A series of 
measures have been introduced to improve the quality of bioprocess designs generated from 
IAPBD.  
1. The agents were tested on simulated virtual devices before linking them with real 
instruments. Using the simulation packages provided by Tecan EVOware, 
experiments were firstly carried out on simulated LHS with 3D view, and each step 
was monitored and verified manually. The design algorithms in Experiment Design 
Agent were tested by simulation data generated from Assay Agent. 
2. A routine check will be performed on LHS each time before running real 
experiments. The check is to perform series pipetting tasks on a microwell plate. 
Then, %bias and %CV will be measured to evaluate performance of LHS as 
reviewed in Chapter 1. 
3. During execution of experiments, the liquid level in each microwell will be 
measured after each pipetting task. The measured volume will be compared with 
theoretical value to make sure that %bias is within defined range (i.e. <=5%).  
IAPBD will be suspended if abnormal %bias was observed.  
4. MAD of replicates’ result from Assay Agent will be calculated for outlier detection 
as reviewed in Chapter 1. The design algorithm will ignore data from outliers. 
5. IAPBD will be suspended when hardware failure has been detected. Since 
automated devices (e.g. LHS, HPLC, plate reader) usually have failure detection 
functions built in, IAPBD continuously monitors hardware status and suspends all 
operation in the case of hardware failure. 
 
2.5 Conclusions 
An intelligent automation platform with multi-agent architecture is established to realise the 
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closed-loop learning approach in bioprocess development. An ERM based database has 
been designed to store the data of historical experiment results, system configuration and 
other general knowledge. Five agents in the platform communicate with each other via the 
blackboard mechanism, where everyone can read and write new messages for 
experimentation progress. The platform integrates the current independent parts including 
automated devices, analytical instruments and intelligent experiment design algorithms 
together to perform the bioprocess design tasks. The platform learns from each batch of the 
experiment results, and tries to achieve better bioprocess design based newly gained 
knowledge iteratively. There are several significant advantages of this approach: 
• Researchers are completely free from the simple and repeatable tasks such as liquid 
handling and plate transfer. 
• Experimental data can be well organized and analysed.  
• Integrating the microscale instruments into the platform would reduce the material 
cost. 
• Different algorithms or methods related to experiment design could be implemented 
quickly and straightforward. 
In next three chapters, the agent development will be discussed further through several case 
studies and the performance of IAPBD will be evaluated using real examples. 
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Chapter 3 IAPBD verification by a lysozyme precipitation process design 
 
3.1 Introduction 
The intelligent automation platform established in Chapter 2 based on the closed-loop 
framework and the multi-agent architecture is designed to be capable of driving all relevant 
automated devices, analytical instruments and experiment design and data analysis 
algorithms. A case study of a precipitation process has been carried out on the platform for 
the purpose of verification and demonstration. This case study is deliberately chosen for its 
simplicity so as to verify the functions of the IAPBD. Although the precipitation experiment 
is very simple, it has several common operations such as mixing, incubation, and filtration in 
sample preparation that involved in the most of experiments. A plate reader has realized the 
measurement of protein concentrations.  
The experiment is to investigate the solubility of lysozyme so as to identify the optimal ion 
strength and pH in the precipitation process. Ammonium sulphate and phosphate buffer are 
used to achieve the ion strength and pH values. The goal of the experiments was to find an 
optimal set of conditions that maximizes the yield of lysozyme in supernatant and 
maximizes the ammonium sulphate concentration. Here maximizing the ammonium 
sulphate concentration reflects maximizing the purity for a crude industrial feed. The 
objective function, J, is shown in equation (3.1). 
 
                            J=α(c/c0)+β(s/s0)                   
 
where α and β are weighting factors, c0 the initial lysozyme concentration, c the final 
lysozyme concentration in the supernatant, s0 the maximum ammonium sulphate 
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concentration, and s the ammonium sulphate concentration used in the specific experiment. 
The objective function can also represent the scenario where both yield and purity are 
maximised in complex multicomponent precipitation processes. 
In this chapter, the material and methods for the precipitation will be detailed in section 3.2, 
which describes the procedures for the microscale precipitation experiment. The agent 
designs to realise these procedures automatically and IAPBD implementation will be given 
in section 3.3. In particular, the design of the simplex search algorithm and the ANN 
algorithm in Experiment Design Agent to facilitate the closed-loop learning will be 
described in details. The integration of agents and the automated devices and instruments is 
straight forward as their APIs are available for use. The experimental results achieved by 
IAPBD will be shown in section 3.4 followed with the conclusions.    
 
3.2 Material & Methods 
For our experiments the ammonium sulphate, monosodium phosphate, and disodium 
phosphate were obtained from Sigma-Adrich. The ammonium sulphate solution was 
prepared at a concentration of 4 mol/L. The phosphate buffer was chosen to maintain the 
desired pH value. The monosodium phosphate and disodium phosphate solution are firstly 
prepared at the concentration of 300 mM then diluted. The lysozyme was obtained from 
Sigma-Adrich and prepared at 20 mg/mL. The 96-well Multiscreen filter plates were 
sourced from Millipore (Hertfordshire, U.K.) and the 96-well ﬂat bottom Costar UV 
Microwell plates from Corning (Leicestershire, U.K.). 
The experiment involves adding 100 µL of lysozyme solution and 50 µL of buffer solution, 
a mixture of monosodium phosphate and disodium phosphate, into the microwell. Thus, the 
initial lysozyme concentration in each well is 6.67 mg/mL. The ammonium sulphate 
concentration ranges from 0 to 1 mol/L. The range of pH is between 6 to 8. The interval of 
ammonium sulphate concentration was 0.1 mol/L and the interval of pH is 0.1. The 
incubation time was 2 hours. 
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Figure 3.1 Calibration curve of the absorption at 280 nm and lysozyme concentration.  
  
 
A Tecan Freedom 200 LHS executes all of the liquid handling tasks. The hardware 
configuration of the intelligent automation platform for precipitation is shown in Figure 3.2. 
A Tecan Infinite 200 plate reader is used to detect the lysozyme concentration at absorption 
of 280 nm. The calibration curve shown in Figure 3.1 confirmed that the absorption at 280 
nm was good for lysozyme measurement. A vacuum separator from TecanVacS series is 
performed for the filtration operation.  
The simplex search method and artificial neural network (ANN) model-based method are 
chosen as the sequential experiment design methods in this study.  
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Figure 3.2 Hardware configuration of intelligent automation platform for precipitation. (1) 
disposable tips rack; (2) tube carrier; (3) 96-well microplates carrier; (4) vacuum filtration; 
(5) UV plate reader 
 
 
3.3 IAPBD implementation for protein precipitation experimentation  
Based on the framework from Chapter 2, the prototype for lysozyme precipitation process 
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development has been established and is illustrated in Figure 3.3. The data and knowledge 
base initially stores the system configuration information of the devices, e.g. Tecan 
configuration. The configuration information in the database consists of both connection 
parameters to realize communication among devices and the dimension and layout 
information to guide the movement of the robotic arms during the execution of experiments. 
Any experiment designed later can be translated automatically into executable programs to 
drive the devices. The experimental results obtained later will also be stored in the database. 
The database uses a ERM in Microsoft Access. 
 
 Experiment results
 System configuration 
information
Data & knowledge base
 Simplex search algorithm
 Artificial neural network 
modelling algorithm
Sequential design method  Sample preparation in 96 microplate using Tecan 
Liquid handling system
 Incubation and shaking in 
Tecan Infinite 200
 Separate the mixture using 
Tecan Vas and microplate 
filter
Execution of experiments
 Collect raw data (xml file)
 Calculate the objective 
function
Data treatment
 Absorption at 280nm 
measured by Tecan Infinite 
200 plate reader
Assay on protein 
concentration
 
Figure 3.3 Multi-agent architecture used in IAPBD for precipitation process design 
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The experiments carried out include sample preparation in a 96 micro filter plate, incubation 
and shaking by plate reader, and liquid and solid separation of the samples by a vacuum 
pump sucking out the liquid from the bottom of the micro filter plate (Figure 3.3). All of 
these have been carried out by a Tecan LHS and driven by designated experimental 
procedure software in the EVOware. 
The plate reader is located next to the Tecan and within the reach of the robotic arm. The 
lysozyme optical density is measured at 280nm UV absorption and the data stored in an 
XML file. Data treatment software that converts the raw data into lysozyme concentration 
based on calibration curves is also stored in the database. 
The sequential design method uses the experimental data to calculate the objective function 
to decide if it is necessary to design a next round of experiments and use simplex search 
algorithm or artificial neural network modelling algorithm to design the next round 
experiments required. The experiment results and the newly designed experimental 
conditions are stored in the database for further use. 
 
3.3.1 Multi-agent based architecture for precipitation process design 
Based on the architecture explained in Chapter 2, the architecture for lysozyme precipitation 
process development has been established as shown in Figure 3.4.  
The Coordinate Agent retrieves the historical experiment data from database and writes the 
new executed experiment results into the same database. It also translates the information in 
the database in the message format to blackboard.  
The Execution Agent controls the robotic arm (Tecan Freedom 200) to add the lysozyme 
solution, phosphate buffer and ammonium sulphate solution into the microwell plate. The 
different pH values of each experiment were achieved by mixing suitably calculated 
volumes of monosodium phosphate and disodium phosphate solution. Then the agent 
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controls the LHS to put the microwell plate into incubator and controls the shaking speed 
and time. After incubation and shaking, the agent controls a vacuum pump on the platform 
to separate the precipitates and liquid. Finally the agent controls the robotic arm to take the 
sample of permeation to the plate reader to detect lysozyme concentration.  
The Assay Agent controls the plate reader directly via its API. It communicates with the 
Coordinate Agent when the experiments carried out for calibration if there is insufficient 
data from the Coordinate Agent. Based on the calibration results, the agent reads data from 
the plate reader and calculates the lysozyme concentration of each well.  
The Experiment Design Agent comprises two algorithms, which are the simplex search 
algorithm and the artificial neural network algorithm. Based on these algorithms, the agent 
publishes the newly designed experiments on blackboard for execution. 
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Figure 3.4 Multi-agent architecture for lysozyme precipitation process development 
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3.3.2 Experiment Design Agent: simplex method 
The simplex algorithm, first proposed by John Nelder & Roger Mead (Olsson & Nelson 
1975), is designed for minimizing an objective function in a multi-dimensional space. The 
technique was soon applied to solve bioprocess optimization problem (Ghodbane & 
Guiochon 1988; Konstantinidis et al. 2012; Horstkotte et al. 2010). The algorithm is 
significantly powerful as it only uses function values instead of the whole profile of response 
surface. It does not require the derivative term of objective function like majority 
search-based optimization algorithms. This feature makes the simplex algorithm popular in 
searching for optimal solution in experiment associated applications. Every iteration only 
one or few experiments are designed, which drastically reduces the experiment number 
compared with other experiment design methods. The procedures of the algorithm are 
detailed below. 
0. Generate initial experiments. 
Given the number of input parameters is n, (n+1) experiments are generated where 
value of each input parameter can be randomly picked within the defined feasible 
range. The experiments are transformed into the vectors according to the value of 
inputs and outputs: 
s = [C=, CP, … , C-, t=, tP, . . , t,] 
These experiments are initial simplex. Add unfinished experiments in the simplex 
into set, S. 
1. Execute  
a. Remove the completed experiments from S. 
b. Execute the experiments in set S. 
2. Sort.  
a. Check whether experiments in current simplex have been done. If not, add 
unfinished experiment to set S, and go to step 1. 
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b. The objective function is v s . According to the value of objective function, 
sort the experiments 
v L= ≤ v LP ≤ ⋯ ≤ v(L-[=) 
c. Compute the variance of all the experiments (ss) in the current simplex 
EE = 17 + 1 v L@ − 17 + 1 v(L@)-[=@`9 P-[=@`9      
d. If ss is less than the given accurate factor, i, then output the result and 
terminate the algorithm, else go to step 4. 
3. Calculate the centre of the gravity of all points 
L9 = L@-@`=7  
4. Reflection 
a. Compute the reflected point L) = L9 + (L9 − L-[=) 
b. Check whether L) has been done or not. If not, add L) into S, and go to step 
1. 
c. If the point is better than the worst, but not better than the best, i.e. v L= ≤ v L) ≤ v(L-) 
Then obtain a new simplex by replacing the worst point with the reflected 
point, and go to step 2 
5. Expansion 
a. If the reflected point is the best point so far which means v L) ≥ v L- , 
then calculate the expanded point, L+ = L9 + 1.5(L9 − L-[=) 
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b. Check whether L) has been finished or not. If not, add L+ into S, and go to 
step 1. 
c. If the expanded point is better than the reflected point, v L+ ≥ v L- , then 
obtain a new simplex by replacing the worst point with the expanded point, 
and go to step 2. 
d. Else, obtain a new simplex by replacing the worst point with the reflected 
point, and go to step 2. 
6. Contraction 
a. Compute contracted point, Lz = L-[= + (L9 − L-[=) 
b. Check whether L) has been completed or not. If not, add Lz into S, and go 
to step 1. 
c. If the contracted point is better than the worst point, then obtain a new 
simplex by replacing the worst point with the contracted point, and go to step 
2. 
d. Else go to step 8 
7. Reduction 
a. For all but the best point, replace the point with L@ = L= + 0.5(L@ − L=) 
Go to step 2. 
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Figure 3.5 The experiment design agent to facilitate the simplex search algorithm  
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3.3.3 Experiment Design Agent: ANN 
ANNs provide a range of powerful new techniques for solving problems in sensor data 
analysis, process identification, and control and have been used in a diverse range of 
chemical engineering applications (Pirdashti et al. 2013). Inspired by the way biological 
nervous systems, ANN is composed of a large number of highly interconnected processing 
elements (neurones) working in unison to solve specific problems. Feed-forward ANNs are 
one of popular architectures of neural network. As shown in Figure 3.6, Feed-forward ANNs 
allow signals to travel one way only, from inputs to output. There is no loop, i.e. the output 
of any layer does not affect that same layer. They are widely used to model non-linear 
systems (Khosravi et al. 2011). 
The Back-Propagation Algorithm was invented to train ANNs, i.e. to adjust the weight of 
each neuron in such a way that the error between the desired output and actual output is 
reduced (Werbos 1990). The process requires that the ANN compute the error derivative of 
the weights (EW). EW describes how the error changes as each weight is increased or 
decreased slightly. The Gradient Descent algorithm can be then applied to train the ANN 
iteratively.  
The Back-Propagation is used as the teaching methods of the ANN in this case study. The 
activation function for each neuron is sigmoid function as follows. 
v { = 11 + LWc                       
Thus the output value for each neuron in the network can be expressed as follows. 
|@} = v ~@}|}W=                    
where |@}	is the output value of ith neuron at kth layer, and ~@} is the weight value between 
ith neuron in kth layer and jth neuron in (k-1)th layer. 
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The steepest descent method is used here to adjust the weight values in the network. First, 
the error function is defined in the following expression. 
L = 12 |@, − Å P@                                            
where Y is the result from the experiment and |@, is the output given from the network. The 
adjustment for the weigh value for one iteration can be expressed as follows.  
∆~@ = −< ÉLÉ~@                        
The following equation explains how to compute new weight value from the last iteration. 
~@ Ñ + 1 = ~@ Ñ − < ÉLÉÖ@} |}W=               
A single hidden layer artificial neural network is represented in Figure 3.6. There are two 
nodes in the input layer representing salt concentration and pH value. 10 neurons are in the 
hidden layer. The output layer contains one neuron since there is only one response 
parameter (lysozyme concentration in the supernatant).             
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Figure 3.6 Schematic of a single hidden layer neural network 
 
After defining the mechanism of the neural network, in order to save the experimental 
materials, the flowchart (Figure 3.7) demonstrates the procedures for the system to execute 
experiments in a batch-by-batch manner. The first three batches of experiments are firstly 
carried out on IAPBD as training set, validation set and testing set. The ANN is then trained 
by training set and validation set. If value of error function, which is calculated based on 
data in testing set, is larger than pre-defined threshold, another batch of experiments will be 
carried out on IAPBD as new testing set, while old testing set is used for training of ANN  
until ANN provides satisfactory prediction of lysozyme concentration. 
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Figure 3.7 The Experiment Design Agent to facilitate the simplex search algorithm 
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3.4 The lysozyme precipitation process development 
The Execution Agent and Assay Agent drove the TECAN liquid handling system and the 
plate reader automatically. The communication between the coordinator agent and other 
agents was smooth in facilitating data exchange. Two lysozyme precipitation studies were 
carried out. The Experiment Design Agent used the simplex search algorithm in the first 
study and the ANN algorithm in the second study.  
 
3.4.1 Precipitation optimization using the simplex algorithm 
The initial simplex was selected randomly to mimic a new process design task when no prior 
knowledge was available. The Experiment Design Agent then designed sequentially 16 new 
experiments based on the simplex algorithm. The optimal point was found after 16 iterations. 
The maximum value of the objective function was 0.70, where the ammonium sulphate 
concentration was 0.8 mol/L and the pH was 7.1. The corresponding lysozyme 
concentration was 6.05 mg/mL. As shown in Figure 3.8, the objective value jumped from 
0.14 to 0.50 after only the first set of iterations, which proves that the simplex algorithm is 
very effective when searching for the extreme point in the given space. When the 
ammonium sulphate concentration was lower than 0.8 mol/L, the solubility of lysozyme 
stayed almost the same so that the objective function value decreased. When the ammonium 
sulphate concentration was higher than 0.8 mol/L, the rapid decrease in the solubility of 
lysozyme made the objective function decrease. Also, the impact of pH on the solubility was 
less than that of the ammonium sulfate concentration. Figure 3.9 shows the response surface 
extrapolated from these 18 data points. It confirms that the optimum point found reached a 
relatively high objective function value.  
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Figure 3.8 The objective function increases with the number of iterations in the simplex 
search algorithm 
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Figure 3.9 The estimated surface of the objective function based on all 18 experimental 
points  
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3.4.2 Precipitation optimization using the ANN algorithm 
The initial five experiments were selected randomly. After four iterations, the model 
achieved the desired accuracy. The response surface of the predicted lysozyme 
concentration in the soluble phase that was achieved is shown in Figure 3.10. When the 
ammonium sulphate concentration was higher than 0.8 mol/L, the lysozyme concentration 
decreased rapidly, similar to the results from the simplex algorithm. At same time, pH had 
little impact on the solubility of lysozyme. According to the model generated by the network, 
the highest objective function value was found at 0.7 mol/L of ammonium sulphate 
concentration and pH of 7.0, as shown in Figure 3.11.  
 
 
 
Figure 3.10 The predicted lysozyme concentration response surface at various ammonium 
sulfate concentrations and pH values by the ANN method 
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Figure 3.11 The predicted objective function surface from the ANN method.  
 
 
The results from two precipitation studies demonstrated the capability of the Experiment 
Design Agent. Both of the sequential experiment design methods delivered the process 
design solution successfully. At each iteration, the communication was also very efficient 
since the time used for communication, data analysis, and experiment design in the above 
studies was less than 1 min, which significantly saved the process design time.  
 
3.5 Conclusions 
A first prototype of the intelligent automation platform to perform precipitation experiments 
automatically has been established. The platform is able to drive liquid handling robotic arm, 
vacuum pump, shaker and plate reader together to perform all of the procedures such as 
assembly adding, shaking, incubation, uv absorption measurement automatically without 
human involvement. The closed loop learning was achieved by using simplex search 
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algorithm and neural network modelling that the experiments were selected iteratively until 
the final design solution was found. The 5 agents worked together to select the initial 
experiments, drive the LHS to execute experiments and the plate reader to measure the 
protein concentrations, and control the simplex algorithm or the ANN algorithm to carry out 
data analysis then identify the next batch of experiments. The whole experimental procedure 
works smoothly.  
The case study demonstrated two different algorithms: simplex algorithm and artificial 
neural network. The simplex algorithm shows its power when searching extreme points in a 
defined space, while thee neural network modelling approach gives a better understanding 
of the effect of lysozyme solubility at various ion strengths and pH values. The ‘intelligent’ 
experimental design by these algorithms can keep the number of experiments low. The 
results obtained from the platform are reliable and same as those from the manual operations 
(data not shown). 
The intelligent automation platform that integrates experiment devices, database, and 
algorithms for experiment design has been demonstrated as a powerful tool for high 
throughput process development.  
The IAPBD has successfully achieved the automation of high throughput precipitation 
experimentation. The realisation of the automation has made the time spent on the data 
analysis and experiment design negligible. The outcome on time reduction in data analysis 
and experiment design has fulfilled the goal of the intelligent automation platform. The time 
saving in this simple experiment means the potential time saving in complex bioprocess 
development may be even more significant. The elimination of time delay during 
experiment procedure and utilization of intelligent experiment design in intelligent 
automation platform has reduced time needed and make the platform a very effective 
process optimization tool.  
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Chapter 4 IAPBD implementation in a monoclonal antibody precipitation 
process design 
 
4.1 Introduction 
The advance in mammalian cell culture has increased the monoclonal antibody production 
titre to 10 g/L or higher (Low et al. 2007). The efficiency of upstream processes presents 
challenges for downstream antibody purification processes to achieve both product quality 
and cost efficiency. In a typical downstream purification process, the impurities from 
mammalian cell culture includes proteins, host genomic DNA, endotoxin and other potential 
hazards such as allergy molecules (Wurm 2004), all of which must be removed after 
downstream processes for the therapeutic antibody product. The residual in the final 
antibody product must be controlled within an extremely low level for safety purpose 
according to the requirements from FDA. Currently, the downstream processes for mAb 
purification usually starts with protein A chromatography because the affinity 
chromatography with protein A has been proven to be the most effective purification step for 
mAb and is capable of achieving 95% purity after one single step depending on the 
compositions of feedstock (Shukla et al. 2007; Sommerfeld & Strube 2005; Roque et al. 
2007). 
The disadvantage of protein A chromatography, however, is significant during large scale 
high titres feedstock. Protein A resin has relatively low binding capacity, while its cost is 
very high. In the large scale downstream purification processes, a large amount of expensive 
protein A resin is required to capture MAb. Furthermore, the reduced wall support in a very 
large diameter column and physical properties of the beads will slow the flow rate due to the 
increasing pressure drop (Stickel & Fotopoulos 2001) and could reduce the robustness of the 
process. Thus, the volume of column has to be controlled within the limit. This leads to the 
parallel batch mode is widely adopted in MAb purification by increasing the number of the 
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columns. However, this approach demands a large initial capital investment and higher 
operation cost. A lot of research works have tackled the challenge by improving the binding 
capacity or beads rigidity (Hober et al. 2007). The manufacture cost will still be high due to 
a large number of processing cycles, high concentrations of column-fouling materials such 
as cell debris or lipids, and more frequent use of harsh cleaning agents (Tugcu et al. 2008). 
Therefore, a cost effective purification solution which is able to reach comparable quality 
results of protein A chromatography, as well as easy to fit into current large scale 
manufacture system, is extremely desirable (Shukla & Thömmes 2010). 
The precipitation process for MAb purification presents a promising solution. The 
precipitation process is the technique that uses the differences of protein solubility to 
precipitate components to separate proteins. It has been reported to be promising in 
industrial production due to ease of operation and clean products in the later refining stages 
(Thömmes & Etzel 2007). Ammonium sulphate is extensively used in precipitation process 
because of both its high salting out effect and small impact for protein denature (Cheng et al. 
2006).  
Traditionally, in order to meet the quality requirements, polishing processes are demanded 
after protein A chromatography to further remove impurities, e.g. host cell protein, genomic 
DNA etc. (Li et al. 2005; Shukla et al. 2007). Ion exchange chromatography (IEX) is an 
important polishing step. It separates proteins based on protein charge differences. 
Therefore, ionic interactions, the type of resins, buffer condition and protein properties have 
significant effect on process efficiency.  
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Figure 4.1 Two downstream purification processes: (a) protein A chromatography platform; 
(b) precipitation based platform. (Ji 2012)  
 
Furthermore a recent work proposed a mAb purification process that includes two-step 
precipitation and anion exchange chromatography (AEX) (Ji 2012). The precipitation and 
depth filtration are used to remove impurities before AEX. The two process routes are 
shown in Figure 4.1. Based on Ji’s model based optimization approach, the precipitation 
based purification platform achieved very comparable results and the operating cost has 
been significantly reduced based on his estimation.  
A “step by step” approach is often used to optimize a sequence of unit operations. Each step 
is assumed to be independent from other steps. Thus, each step has been optimized 
individually during the process design. However, some studies showed that the interactions 
do exist among those unit operations (King et al. 2007; Rayat et al. 2010). For example the 
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interaction between the homogenisation for cell disruption to release an intracellular protein 
and the centrifugation for removal cell debris was reported (Siddiqi et al. 1996). As both of 
the precipitation and the chromatography process are targeting protein separation, some of 
the impurity proteins may be removed only by the precipitation, some by the 
chromatography and some by both. The different step one operation will lead to different 
feed material for step two. Hence the interaction between the two steps is likely to exist at 
some extends in principle.  
Another reason of using the “step by step” approach may be due to the practical difficulty 
encountered in manually organising the two-step operations at pilot scale. With the advance 
in the microscale experimentation technology and the automation technology, multi-step 
process experimentation becomes manageable.  
In the two-step precipitation and AEX process, some impurities may be removed relatively 
easily via AEX comparing with precipitation, while the other can be precipitated out with 
ease. In that case, the optimal condition may be achieved by studying related unit operations 
together so that each unit operation can have best performance. By examining two different 
optimization approaches, as shown in Figure 4.2, the interaction exist between these two 
steps can be investigated. Approach (a) is the optimization of each unit operation separately. 
Approach (b) is to use the optimal conditions in AEX obtained from Approach (a) to purify 
the feed material first, and then optimise the precipitation step. My hypothesis is the results 
from these two approaches will be the same if there is no interaction between them. . 
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Figure 4.2 Two different approach for process optimization that involves more than one unit 
operations 
 
Another purpose for the case study is to demonstrate that the platform is able to integrate 
with the automated devices that do not have the APIs. HPLC is the workhorse for protein 
quantification. It will be used to quantify mAb and impurity protein concentrations in the 
case study. Since the HPLC systems do not have the programmable interface, the 
architecture in the Assay Agent in the previous case study is not feasible anymore. Instead of 
controlling the HPLC directly from the agent, an online watcher program has been 
developed to monitor the operation status of HPLC system and to report back the raw data to 
Assay Agent. 
In the case study, a mAb precipitation optimization will be firstly carried out to further 
evaluate the platform, which is integrated with a separated device (e.g. HPLC). 
Experimental results will be benchmarked with those from Ji's work (Ji 2012), which were 
done manually. The selected precipitation condition will be used to perform a two-step mAb 
purification process, which include precipitation and AEX. The operation condition for 
AEX will be chosen according to result from Ji's study (Ji 2012).  
The next step is to investigate the interaction between precipitation and AEX. The feedstock 
will go through AEX first using the same pH and ion strength. Then, another round 
precipitation optimization will be performed on the platform. If our assumption is valid, 
higher yield and higher purity of mAb is expected. 
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In summary, there are two purpose of the case study as discussed before: 1) verification of 
the platform integrated with instruments, which do not have programmable interface (e.g. 
HPLC); 2) examination of the interaction between precipitation and AEX in mAb 
purification process. 
4.2 Materials and Methods 
4.2.1 Materials 
4.2.1.1 Cell culture and mAb production 
A humanised IgG4 type monoclonal antibody (mAb) was expressed extracellular by the 
CHO cyol cell line which was developed and authorised by Lonza (Slough, UK) for 
culturing in Biochemical Engineering Department at UCL. The pI of the mAb is 7.4 to 7.8 
measured by isoelectirc focusing gel. The cell culture broth was produced by my colleague 
following standard procedures (Popova et al. 2015). The cell culture was harvest at mAb 
concentration around 1g/L. It was then processed at 10,000 rpm by Eppendorf Cenrifuge 
5810R for 30min and then filtered through a 0.22 mm filter. 
The clarified cell culture broth was stored in a -70 oC freezer. For each set of experiments, 
the same batch of cell culture was used. The concentrated material was diluted by PBS to 
required mAb concentration in the following studies. 
 
4.2.1.2 Chemicals 
Sodium monobasic phosphate, sodium dibasic phosphate, and ammonium sulphate et al. 
were purchased from Sigma Chemical Co. Ltd. (Dorset, UK). All chemicals were reagent 
grade. Ethanol and other HPLC solution were HPLC analysis grade.  
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4.2.1.3 Antibody standard 
MAb standard were produced by Protein A chromatography. MabSelect Hitrap 5ml column 
(GE Healthcare, Sweden) was equilibrated in pH 7.4, 0.15 M sodium chloride, 20 mM 
sodium phosphate buffer with 1 ml/min flowrate on AKTA Basic (GE Healthcare, Sweden). 
The feedstock was buffer exchanged to pH 7.4 loading conditions in Millipore 5 kDa 
concentration tube (Millipore Limited, Dundee, UK) and loaded onto the column. Three 
column volumes of the loading buffer was followed to wash the column and one column 
volume of the loading buffer with 10% (v/v) isopropanol was used to wash out hydrophobic 
impurities. Then, mAb was eluted by 100 mM, pH 3.5 sodium citrate buffer at 1 ml/min. 
Then immediately add 50 µl per 1 ml elution 1 M pH 9.0 Tris buffer to neutralize and protect 
antibody. Loading, washing, elution and fraction collection were executed and monitored by 
AKTA Basic with Unicorn software (GE Healthcare, Sweden).  
 
4.2.2 Methods 
4.2.2.1 Micro scale precipitation 
The mAb precipitation was carried out in the 96 microwell filter plate with 0.45 µm 
Durapore membrane (Millipore Limited, Dundee, UK) by Tecan robot (Tecan Group Ltd., 
Switzerland). Since the mAb formed lipid-like precipitate, it required higher mixing speed 
and only filtration can successfully separate solids from liquid. The precipitation conditions 
chosen were pH from 5.0 to 8.5 with an interval of 0.5, ammonium sulphate concentration 
from 0.6 mol/L to 2.2 mol/L with an interval of 0.2 mol/L. Acetate buffer was used for pH 
5.0 to 5.5 and phosphate buffer for pH 6.0 to 8.5. The total volume of small-scale 
precipitation was 250 µl, including salt solution, 20 mM pH buffer, distilled water and mAb 
solution. 25 µl pH buffer was first aspired from 200 mM stock solution and added into each 
microwell, followed by required volume of 4 M ammonium sulphate stock solution and 
water. The microwell plate was then mixed in the Eppendorf thermomixer for 15 mins to 
avoid unevenly distributed solution before dispensing 50 µl feedstock. The precipitation 
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plate was incubated at 20 oC with a microwell lid on and mixed in Eppendorf thermomixer at 
1000 rpm for 2 hours. Then microwell plate was placed into vacuum separator, Te-VacS 
(Tecan Group Ltd., Switzerland) with a 96 microwell receive plate underneath. Clear 
permeate was transferred to Agilent 96 micro-well plate by robotic arm for HPLC analysis. 
. 
4.2.2.2 Anion exchange chromatography 
Pre-packed 1mL HiTrap Capto Q (GE Healthcare, Sweden) was used in the case study for 
anion exchange chromatography. AKTA basic was used to connect columns and control 
purification steps. The conditions of loading buffer were pH 7 by 5mM sodium citric buffer 
and sodium chloride with concentration of 1ms/cm. 5 column volumes of loading buffer was 
applied to HiTrap column first. The antibody feedstock was buffer exchanged to pH 7 
loading conditions and loaded to column at 1ml/min flowrate. Fraction collection was then 
used to collect elute with 1 ml each tube for 1 ml column. Collected elution at main peak was 
kept together in +4oC fridge. 
 
4.2.2.3 Bradford total protein assay 
Bradford protein assay was used to analyze the total protein concentration in the samples. 
BSA standard and Bradford protein assay kit were bought from Sigma-Aldrich (Dorset, UK). 
PBS was used to dilute samples and worked as blank. All samples were diluted to be in 0-40 
µg/ml range, which was the standard and assay working range. 1 ml of standards, controls 
and samples were transferred to cuvettes and then 1 ml Bradford reagent was added. Each 
cuvette was well mixed and covered from light for 10 minutes at room temperature 
(Bradford, 1976). Both 2 ml cuvette and transparent 96 microwell plates, if samples were 
transferred from cuvettes, can be used to take samples and test at UV 595 nm. The total 
protein concentration was then calculated based on the corresponding calibration curve. 
Figure 4.3 shows the calibration curve of total protein concentration using Bradford assay. 
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Figure 4.3 Calibration curve of total protein concentration using Bradford assay 
 
4.2.2.4 mAb HPLC analysis 
The mAb concentration was measured by a 1 ml protein G HiTrap column (GE Healthcare, 
Sweden) connected to an Agilent 1200 series HPLC system (Agilent Technologies, UK). ). 
The equilibrium and loading buffer was pH 7.4, 20 mM sodium phosphate. 100 µL sample 
was injected into column with an autosampler. The sequence and methods were 
pre-programmed in HPLC software Chemstation. UV 280 nm signal was recorded and used 
to measure the peak area. The mAb concentration was calculated based on a calibration 
curve, which was generated by several mAb concentration samples, range from 0 mg/ml to 
1.5 mg/ml, diluted from mAb standard. Before samples being loaded into HPLC, they were 
transferred to 96 microwell filtration plates and centrifuged at 1,000 rpm for 10 minutes. The 
permeates were transferred to Agilent 96 microwell plates for HPLC. The flow rate of 
HPLC was kept at 2 ml/min with upper pressure 85 bar limit. Total analysis time is 6 minute 
with mAb peaking at around 3 minute. The calibration curve of mAb concentration by peak 
area using HPLC is shown in Figure 4.4. 
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Figure 4.4 Calibration curve of mAb concentration by peak area using HPLC 
 
4.2.2.5 Impurities analysis 
The overall impurities included host cell protein, cell culture media protein and other 
impurities. These impurities were measured by HPLC at UV 280 nm as the first flow 
through peak. The feedstock was used as the standard. Several samples diluted from 
standard were made according to different dilution rates. The Bradford total protein assay 
was used to measure the total protein concentration in each diluted sample. The impurity 
concentration for each sample was calculated by subtracting the corresponding mAb 
concentration from the total protein in that sample. The calibration curve was then regressed 
from the impurity concentration and HPLC peak area. The regression goodness of fit had 
R-square of 0.99 and random sample tests were validated by Bradford assay. The calibration 
curve of impurity concentration by peak area using HPLC is given in Figure 4.5. 
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Figure 4.5 Calibration curve of impurity concentration by peak area using HPLC 
 
4.3 IAPBD implementation for mAb precipitation experimentation 
The mAb precipitation process has similar experimental procedures as the lysozyme 
precipitation process. The key difference is that the assay for mAb quantification uses HPLC 
instead of the plate reader. HPLC is a stand-alone instrument. Its software does not provide 
the API for integration. Hence the new development illustrated in this section is the Assay 
Agent Design. The other agents use the software developed in Chapter 3.    
 
4.3.1 Assay Agent 
The Assay Agent in this case study is different from that in previous chapter. Instead of 
Tecan platereader, HPLC, which is controlled by Agilent ChemStation (Agilent, US), is 
used to measure protein concentration. Unfortunately Agilent ChemStation does not have 
public APIs, which allow the third party software to control HPLC. Therefore, a new 
approach was proposed and developed to communicate with HPLC in the case study.  
There are two challenges that need to be overcome in order to achieve the process 
automation. The first one is to get the real time experimental information, e.g. status, assay 
 120 
data etc., without direct access to ChemStation. The other one is to convert the raw data such 
as retention time and peak area into protein concentration given that the retention time of 
one protein is not exactly same on each HPLC run. A file watcher was designed and 
programmed in the Assay Agent. The structure of Assay Agent for HPLC communication 
and data analysis is shown in Figure 4.6. 
 
 
Figure 4.6 Structure of assay agent in the case study 
 
The first challenge is solved by continuously monitoring the location where ChemStation 
stores output files. In this way, the agent is able to retrieve the assay data by analyzing the 
latest created data file in real time.  
K-mean clustering algorithm is introduced to overcome the second challenge. By 
monitoring the data file generated by ChemStation, the Assay Agent is only able to retrieve 
the raw data, which are pairs of retention time and peak area. Although the retention times 
for a certain type of protein are supposed to appear at same time at each HPLC run, they are 
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not necessary to be exactly same. Besides, noises on the HPLC spectra sometimes are 
recognized as peaks by ChemStation. Thus, an algorithm is needed to 1) translate the raw 
data into protein concentrations; 2) eliminate the noises in raw data. K-mean clustering 
algorithm embedded in Assay Agent is chosen to gather the similar peaks together based on 
retention times. K-mean algorithm aims to partition n observations into k clusters in which 
each observation belongs to the cluster with the nearest mean. As shown in Figure 4.7, 280 
nm absorption peaks in HPLC forms two clusters around 0.3min and 3 min, which stand for 
impurities and mAb respectively. Therefore, a cluster algorithm is required so that the agent 
can calculate the accurate protein concentration by correctly identifying the mAb's peaks 
from impurity's ones during HPLC assay.  
 
 
Figure 4.7 HPLC retention time distribution among 21 experiment runs 
 
The k-mean algorithm is to firstly define k centres, and then take each point belonging to a 
given data set to associate with the nearest centre until no data point is pending. By 
iteratively updating the centre points from new formed cluster, the algorithm aims to 
minimize squared error function given by: 
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 Ü H = ( N@ − { )Páà`=á@`=   
where, 
N@ − {  is the Euclidean distance between N@ and center point  {	of cluster j. 
I@ is the number of data points in the ith cluster. 
I is the number of cluster centers. 
The detailed steps for the algorithm in our platform are: 
1) Select 2 cluster centers according to predefined retention time stored in the database 
2) Calculate the distance between each data point (peak) and cluster centers. 
3) Assign the data point to the cluster center whose distance from the cluster center is 
minimum of all the cluster centers. 
4) Recalculate the new cluster center using: 
 {@ = (1/â@) N@zà`=   
where, â@ is the number of data points in ith cluster. 
5) Recalculate the distance between each data point and new obtained cluster centers. 
6) If no data point was reassigned then stop, otherwise repeat from step 3). 
Fail safe and quality assurance mechanism is included in the agent. After each peak in the 
dataset has been labelled by clustering algorithm, the agent will convert peak areas into 
protein concentrations according to calibration information stored in the database. In the 
case that one or more protein concentration is missing (i.e. peaks are not recognized by the 
algorithm) for an experiment, the agent will be paused, and experimental data will be 
examined manually. In addition, the outlier detection algorithm as explained in Chapter 2 is 
implemented to insure the data quality of experiment results. 
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From initial test runs, the algorithm was proven to be fast and robust. The mAb and impurity 
concentrations calculated by the Assay Agent automatically were same as the ones that were 
done manually. 
 
4.3.2 Execution Agent 
Same as previous case study, the execution agent controls the robotic arm (Tecan Freedom 
200) to add the feedstock, phosphate buffer and ammonium sulphate solution into the 
microwell plate. The different pH values of each experiment ranged from 6 to 8.5 were 
achieved by mixing suitably calculated volumes of monosodium phosphate and disodium 
phosphate solution for phosphate buffer. And the pH from 5.0 to 5.5 was achieved by mixing 
acetate buffer and sodium acetate solution. Then control it to put the microwell plate into 
Eppendorf thermomixer and control the shaking speed and time. After incubation and 
shaking, it controls a vacuum pump on the platform to separate the precipitates and liquid. 
Finally control the robotic arm to take the sample of permeation to the plate reader to detect 
mAb concentration.  
 
4.3.3 Experiment Design Agent 
The Experiment Design Agent is same as one from previous case study. This case study 
aimed to find out the optimal condition for mAb precipitation other than to explore the 
response surface for the objective function. Hence, instead of model based approaches (e.g. 
ANN), simplex search algorithm is chosen in this chapter. The objective function is defined 
by: 
 
 Ü = ä= ∗ â9 − ââ9 + äP ∗ â9 − âã − â − â$  
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Where, 
ä= and äP are weighting factors for yield and purity. In this case study, ä= equals 0.4, and äP equals 0.6. 
â9 is initial mAb concentration in feedstock. 
â is mAb concentration in supernatant after precipitation. 
â$ is impurity concentration in supernatant after precipitation. 
T is total protein concentration in feedstock. 
Thus, zåWzzå  is mAb yield, while zåWz"WzWzç is mAb purity. 
 
4.3.4 Coordinate Agent 
The Coordinate Agent retrieves the historical experiment data from database and writes the 
new executed experiment results into the same database. It also translates the information in 
the database in the message format to blackboard. 
 
4.4 The mAb precipitation process development 
The execution agent drove the TECAN LHS and HPLC automatically. The Assay Agent 
gathered real time data from HPLC and translated the raw data into mAb and impurity 
concentration successfully. The communication between the coordinator agent and other 
agents was smooth in facilitating data exchange. The Experiment Design Agent used the 
simplex search algorithm in both experiments. Two mAb precipitation studies were carried 
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out.  
4.4.1 1st experiment: mAb precipitation optimization on initial feedstock 
The aim of the mAb precipitation optimization is to verify the IAPBD from the operation 
and the precipitation experiment results. 
Three initial points to form the initial simplex was selected randomly. The initial simplex 
shown in Fig. 4.8 (A) is quite away from the optimal point. One point was found at the 
iteration 2 located on the [1,4, 8] (1.4 mol/L of Ammonium Sulphate and pH value of 8) via 
reflection, and then another point at (2.2, 8) via expansion. Following the procedures 
explained in Chapter 3, the Experiment Design Agent found the optimal point after 5 
iterations as shown in Figure 4.8.  
The maximum value of the objective function was 0.81, where the ammonium sulphate 
concentration was 2.2 mol/L and the pH was 8.  
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Figure 4.8 Illustration of simplex search algorithm on the objective function’s surface. The 
designed experiment points are shown as the black dots. The number near the black dot is 
the iteration number. The final optimal point is shown in small red circle. 
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The corresponding mAb concentration in the permeate was 0.001 mg/mL, whereas impurity 
concentration was 0.813 mg/mL.  
As shown in Figure 4.9, when the ammonium sulphate concentration was lower than 1.3 
mol/L and pH was lower than 6.5, little precipitation occurred and the solubility of both 
mAb and impurity stayed almost the same so that the objective function value stayed almost 
the same. When the ammonium sulphate concentration was higher than 1.3 mol/L, the 
solubility of mAb decreased rapidly while the impurity concentration stayed almost at the 
same level. So the objective function increased when ammonium sulphate concentration 
was higher than 1.3 mol/L. The impact of pH on the solubility was less than that of the 
ammonium sulphate concentration. The solubility of both mAb and impurity decreased a 
little when pH was larger than 7. 
As shown in Figure 4.8, the objective value jumped from 0.09 to 0.80 after only the first set 
of iterations, which again proves that the simplex algorithm is very effective when searching 
for the extreme point in the given space. As shown in Fig. 4.10, the objective function 
surface has strong nonlinearity. It will require a large set of data to characterize such process. 
This case study has demonstrated that the simplex algorithm has the potential to reduce the 
experiment load without compromise the quality of process design. 
The raw data was benchmarked with the results in Ji’s research (Ji 2012). The mAb 
concentrations under same condition of ammonium sulphate concentration and pH value in 
supernatant is comparable with his data. 
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Figure 4.9 mAb and impurity concentration surface under different pH and ammonium 
sulphate concentration in 1st run. 
 
Figure 4.10 Objective function surface under different pH and ammonium sulphate 
concentration in 1st run. 
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4.3.2 2nd experiment: mAb precipitation optimization on elute from AEX 
The feed material was collected from the elution of AEX process at the conditions as 
explained in Section 4.2.2.2. The same procedures applied in the 2nd experiment run on the 
automated platform. Starting with 3 random selected pH and ammonium sulphate 
concentration, the optimal objective function was found after 6 iterations. The maximum 
objective function was 0.87 where pH value was 5 and ammonium sulphate concentration 
was 2.2 mol/L. 
Because of the AEX purfication, the remaining impurity concentration was about  half of 
the initial concentration in feedstock. Besides the difference in impurity concentration, the 
surface of both mAb and impurity were almost identical to that in 1st experiment run as 
expected. Both mAb and impurity were more sensitive with ammonium sulphate 
concentration. The mAb concentration dropped rapidly when ammonium sulphate 
concentration was larger than 1.3 mol/L. The impact of pH was smaller than that of salt 
concentration. The solubility of both mAb and impurity decreased when pH value was more 
than 7. 
However, there were some differences between the 1st run and the 2nd run. The impurity 
was less sensitive to the salt concentration when the salt concentration was less than 1.4 
mol/L. As seen in Figure 4.12, the objective function surface was smoother when the salt 
concentration is less than 1.4 mol/L. Furthermore, the impact of pH was even less in the 2nd 
run comparing to the 1st run. Thus, the maximum objective function was found at pH value 
of 5 instead of 8 in the 2nd run. 
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Figure 4.11 mAb and impurity concentration surface under different pH and ammonium 
sulphate concentration in 2nd run 
 
Figure 4.12 objective function surfaces with different pH and ammonium sulphate 
concentration in 2nd run 
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4.3.3. Comparison study of a two-step mAb purification process   
The optimal precipitation conditions as shown in Table 4.1 obtained from two precipitation 
experiment runs were used in a two-step purification process to further evaluate final purity 
and yield of mAb. 
Table 4.1 Conditions selected for two-step purification process 
 Conditions 1st run 2nd run 
Precipitation 
(NH4)2SO4 (mol/L) 2.2 2.2 
pH 8 5 
AEX 
Conductivity (ms/cm) 1 
pH 7 
 
Two experiments were carried out manually at which scale using different conditions 
defined in Table 4.1, and results are shown in Figure 4.13. The purity in the According to the 
results, the purity in the 2nd run has increased 6.3% while the yield has decreased only 2.6%. 
The objective function value from the 2nd run is also slightly higher that that from the 1st run. 
Therefore, our assumption that there are interactions among unit operations is valid. There 
are a group of impurity proteins in the feedstock that can be removed by either the 
precipitation or the AEX column. Hence the precipitation conditions will impact on the 
removal of this group of proteins at different extends. The performance of bioprocess can be 
further improved by considering more than one unit operation during optimization process. 
The integrated optimization approach includes one shown in Figure 4.2. The output of latter 
optimized operations can be an input for the previous operation for optimization. The 
bioprocess thus can be optimized by several iterations illustrated in Figure 4.2. However, 
this approach may be time demanding. The better solution is that all operations are 
processed in one step if the combined experiment procedure is feasible at microscale. In this 
case, all four factors can be regarded as input parameters for IAPBD.  Because of the high 
throughput technology, the capacity of the platform can then be better utilized to achieve 
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higher efficiency of bioprocess development. 
  
Figure 4.13 (A) mAb purities from the conditions selected by 1st run and 2nd run. (B) mAb 
yield from the conditions selected by 1st run and 2nd run 
 
4.5 Conclusions 
The closed loop learning was achieved by using simplex search algorithm that the 
experiments were selected iteratively until the final design solution was found. The platform 
selects initial experiments from the database, which records the previous experimental data, 
execute experiments and measurement by automated devices, and carry out data analysis by 
design algorithm to identify the next batch of experiments.  
The capacity of IAPBD has been increased by integrating the instruments, which have no 
open APIs. Although the platform cannot drive the HPLC directly, it is now capable of 
monitoring and analysing raw data from HPLC in real time. K-mean algorithm has been 
applied to translate raw data of retention time and peak area into protein concentrations. The 
results obtained from the 1st set of precipitation experiments demonstrate that the platform 
can provide reliable results same as those from manual operations. 
The comparison in the two-step mAb purification study showed the interaction between the 
precipitation and the AEX chromatography exists. The two-step process optimization may 
50.00%
70.00%
90.00%
1st run 2nd run
(A)
50.00%
70.00%
90.00%
1st run 2nd run
(B)
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be realised by the IAPBD using the simplex search algorithm.   
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Chapter 5 IAPBD implementation for fermentation process optimization 
 
5.1 Introduction 
Fermentation is the core technology in biochemical engineering and bioprocessing. 
Developing automated and efficient methods for fermentation process development has 
significant importance for biopharmaceutical industry. Microscale fermentation has been 
studied substantially recently and a range of micro scale devices is commercially available. 
High-throughput approaches for fermentation process optimization have been demonstrated 
as a feasible and efficient method (Halim et al. 2013). They offer significant time and 
resource savings while allowing exploration of a wide range of process variables (Fernandes 
et al. 2006). In the form of micro deep-well plate, shaken mircoscale bioreactors are popular 
because they are inexpensive, widely available and easy to be facilitated on conventional 
LHS (Duetz 2007). The automated approach has been reported to significantly decrease the 
experimental material up to 1000-fold and to increase the throughput up to 100-fold in 
fermentation studies (Micheletti & Lye 2006; Rios-Solis et al. 2013; Du et al. 2014).  
The high throughput experimentation makes experiment design and data analysis a potential 
bottleneck for fermentation studies. Currently, brute force method, which is to explore every 
possibility within the design space, is used as experiment design method in many cases. This 
will require a large number of experiments to be investigated. Although the implementation 
of microscale technologies can dramatically decrease the experimental material, it is still 
desirable to apply advanced experiment design and analysis methods during fermentation 
studies in order to reduce the time consumption of both experiment execution and data 
analysis. There are a few fermentation studies reported using sophisticated experiment 
design methods, e.g. DoE and ANN (Medeiros et al. 2000; Weuster-Botz 2000; Kennedy et 
al. 1992). Those methods were used offline and separated from the automated instruments. 
However, none of those applications has linked the method with the automated instruments. 
However, IAPBD provides a promising approach that can integrate those methods with 
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automated instruments like LHS to perform online experiment design and data analysis. 
In this case study, the benefits of IAPBD are exemplified for optimization of the production 
of a whole cell monoamine oxidase (MAO) biocatalyst. An engineered form of the 
monoamine oxidase from Aspergillus niger (MAO-N-D5) expressed in E. coli is used as the 
biocatalyst to convert amine 3-azabicyclo octane to imine and the reaction is shown in 
Figure 5.1. The product imine (2) is commercially interesting as it can be used as a building 
block in the synthesis of the Hepatitis C viral serine protease inhibitor compounds telaprevir 
and bocepravir (Znabet et al. 2010; Turner 2011). The secondary amine 3-azabicycloctane 
(3-AZA) (1) has been identified as an appropriate substrate for imine production. 
MAO-N-D5 expression and specific activity will be vital to achieve a high reaction turnover 
and a minimum amount of side products formed (Köhler et al. 2010). The case study will 
only focus on final biomass concentration. Many factors will influence cell growth in 
fermentation process such as medium composition and operating parameters. Such a process 
optimization will require substantial amount of effort in general and the statistical DoE 
method is often used.  
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Figure 5.1 MAO-N-D5 mediated oxidation of secondary amine 3-azabicyclo octane (1) to 
the corresponding imine (2). 
 
Another purpose of the case study is to examine Execution Agent’s communication 
mechanism with some instruments that cannot be controlled directly. In many cases, the 
software provided by LHS supplier does not have public APIs for third party software 
integration. For example, Tecan Gemini was used to control an older Tecan LHS model in 
this case study, and Gemini does not have a programmable interface. Thus, Execution Agent 
of IAPBD has been modified in order to inject important data (e.g. volumes of a specific 
reagent needed for each micro well) into Gemini during operation. Similar to the situation in 
the case study in Chapter 4, the plate reader used to measure biomass concentration cannot 
be controlled directly by the Assay Agent either. So a file watcher algorithm will be used for 
the Assay Agent to communicate with the plate reader. 
In this chapter IAPBD is able to utilize the sequential DoE method to achieve high biomass 
growth at micro scale, followed by the large scale comparison study.  Furthermore, 
communication mechanism applied in Execution Agent will be examined as well. 
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5.2 Materials and Methods 
5.2.1 Reagent and cells 
Molecular biology enzymes were obtained from New England BioLabs (NEB, Hitchin, 
UK). Competent E. coli BL21-Gold (DE3) cells were obtained from Stratagene 
(Amsterdam, NL). All other reagents were obtained from Sigma-Aldrich (Gillingham, UK) 
unless noted otherwise, and were of the highest purity available. 
 
5.2.2 Shake flask MAO Fermentation 
Competent E. coli BL21-Gold (DE3) cells were transformed with the plasmid pET16b 
MAO-N-D5 using the heat shock technique described by the supplier (Stratagene, 
Amsterdam, NL). An overnight culture of the transformed cells was obtained in a 100 ml 
shake flask (10 ml working volume) of LB broth (10 g l-1 tryptone, 5 g l-1 yeast extract, 10 
g l-1 NaCl) containing 150 mg ml-1 ampicillin. Growth was performed at 30 oC with orbital 
shaking at 250 rpm using a SI 50 orbital shaker (Stuart Scientific, Redhill, UK). The total 
volume of this culture was used to inoculate a 1 litre shake flask (100 ml working volume) 
which was left to grow for 8 hours.  
 
5.2.3 Microscale automated fermentation 
A Tecan Genesis platform was used for process automation and setup with all required 
polypropylene 96-DSW culture plates, 96-Standard round well plates, reagent troughs and 
disposable microconductive tips (Tecan, Reading, UK). A sterile environment was 
maintained by using UV sterilisation within a Bigneat class 2 biosafety cabinet equipped 
with a laminar airflow system and HEPA filtration (Bigneat Ltd, Hampshire, UK). The UV 
sterilisation step was found to be appropriate as LB-glycerol agar plates left open for a 
seven-hour period after a 20 minute sterilisation process showed no signs of contamination 
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(Baboo et al. 2012). Figure 5.2 (a) shows a real picture of the actual Tecan microscale 
platform with all the components. Figure 5.2 (b) shows a schematic representation of these 
in the Tecan Gemini software used for the programming of operations. The automated 
platform comprised 3 microscale shakers and incubators which were used as fermentation 
units using 96 DSW where temperature and shaking speed could be varied. The 96-DSW 
microwell plate format was adopted in this work for the fermentation steps as this geometry 
was found to ensure the best conditions for oxygen transfer (Duetz 2007; Baboo et al. 2012). 
Microscale fermentations were run in parallel and in triplicate with a fermentation volume 
ranging from 0.5 to 1.5 ml. After the media preparation step, the wells were inoculated using 
10 % v/v of an overnight shake flask culture as described above. Shaking speeds ranged 
from 400 - 1000 rpm. In order to obtain fermentation kinetic data 10 µl samples were 
withdrawn from each well at selected time intervals and diluted in 90 µl of 100 mM 
phosphate buffer using a 96-SRW microwell plate prior to OD600 analysis in the microwell 
plate spectrophotometer. A calibration factor was used to convert all microwell plate 
readings to standard spectrophotometer readings (Baboo et al. 2012).   
 139 
 
 
Figure 5.2 Detail of the microwell automated system. (a) Photograph of the Tecan robot 
deck and ancillary equipment. (b) Deck layout as represented in the Tecan EvoWare 
software: 1) tip washing station, 2) 1000 and 200 µl sterile tip racks, 3) microplate racks for 
biomass sampling, 4) 20 µl sterile tip racks, 5) waste disposal unit, 6) microplate rack for 
colorimetric assay preparation, 7-9) microwell fermentation stations, 10) fermentation 
media containers, 11) microplate centrifuge, 12) microplate microfiltration and low pressure 
unit, 13) HPLC automated rack container, 14) microplate spectrophotometer. 
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Figure 5.3 Schematic representation of the automated platform which performs microscale 
fermentation and biomass concentration measurement 
 
 
5.3 MAO-N-D5 expressing E coli fermentation optimization 
A sequential DoE on 12 factors, which include both operating factors and medium chemicals 
(As shown in Table 5.1), has been used in the case study for fermentation optimization. The 
induction time is included as an input factor because the experiment results were also used 
for a case study for enzyme concentration optimization. 
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Table 5.1 The ranges of operating factors and medium chemicals 
Factors  High Low 
Peptone % w/v 3 0.5 
Yeast % w/v 2 0.5 
Glycerol % w/v 1.5 0.2 
MgSO4 % w/v 0.2 0.01 
NH4Cl % w/v 0.2 0.01 
Na2HPO4 % w/v 0.2 0.01 
K2PO4 % w/v 1 0.1 
IPTG mM 1 0.1 
Shaking rpm 1000 400 
Fill Volume mL 1.5 0.5 
Induction Time hr 8 2 
Temperature oC 44 37 
 
In this case study, the sequential DoE approach was chosen for fermentation process 
optimization. DoE methods, especially factorial designs and mixture design, have been 
proven to be effective to explore the relations among several variables in fermentation 
process optimization (Medeiros et al. 2000; Kennedy et al. 1992; Weuster-Botz 2000). A 
full factorial experiment is the approach whose experimental units take on all possible 
combinations of high and low levels across all factors. It unveils not only the effect of each 
factor on the response variable, but also the effects of interactions among these factors on 
response variable. However, the number of required experiments grows exponentially with 
the number of factors. Given the number of factors k, 2k experiments need to be carried out, 
which usually is too many to be logistically feasible. For example, a two-level full factorial 
design of three factors is to examine all possible combination among high and low levels 
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of all factors as shown in Figure 5.4(A). Thus eight experiments (23) will be investigated in 
total. 
By sacrificing certain degree of regression model resolution, fractional design becomes 
more attractive in most cases. Sometimes the fractional factorial design with relatively low 
resolution is more preferable at early stage for the purpose of factors screening. A 
fractional factorial design consists of a carefully chosen subset (fraction) of the experiments 
of a full factorial design. For example, only four experiments are chosen instead of eight in 
full factorial design as shown in Figure 5.4(B). But some three-way interactions terms are 
confound with two-way interactions. It has been observed that the system is usually 
dominated by main effects and low-order interactions in most cases (Wu & Hamada 2011). 
Thus it is most likely that single factor effects and two-factor interactions are the most 
significant response in factorial experiment. So fractional factorial design reduces 
experimental materials without scarifying model’s predictability. 
Fractional designs are expressed by resolution. Resolution is a term, which describes the 
degree to which estimated main effects are confounded with higher-level interactions. In 
general, the resolution of a design is one more than the smallest order interaction that some 
main effect is aliased with. For example, a resolution-3 design means that main effects are 
confounded with some 2-level interactions. Low-resolution design is often chosen as factor 
screening. For example, in Figure 5.4(B), it is a resolution-4 design because some 
three-way interactions terms are confound with main effects. 
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(A)  (B)  
(C)  
Figure 5.4 (A) Two-level full factorial design of three factors in which all possible 
combinations among high and low levels of three factors are required to be examined. (B) 
Two-level fractional design in which some combinations are ignored to reduce the number 
of experiment runs and some three-way interactions terms are confound with two-way 
interactions. (C) Box-benhnken response surface design for three factorsin which the 
convexity of response surface is studied by introducing central points in experiment runs. 
 
While factorial design leads to a model with only one-degree polynomial model, response 
surface design introduces higher-degree polynomial terms in the model to further estimate 
the convexity of the response surface. Besides experiments of combination of high/low 
levels of each factor that required by 2-level factorial design, response surface design 
includes some central (medium) points. For example, in Figure 5.4(C), additional seven 
experiments will be examined apart from the other experiments located at vertices in 
factorial design. 
Analysis of variance (ANOVA) is usually used to investigate and model the relationship 
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between a response variable and one or more explanatory variables (factors). The 
technique essentially consists of partitioning variation due to the factors and error. Each 
factor consists of two or more levels. ANOVA tests the null hypothesis that the population 
means of each level are equal, versus the alternative hypothesis that at least one of level 
means are not all equal. 
DoE can be executed in sequential manner to reduce the number of experiment runs. It is 
not usually the case that all the factors investigated have significant effect on response. 
Thus, a factor screening design to eliminate the irrelevant or insignificant factors will often 
result in reduction of experiment runs in higher resolution factorial design. 
 
5.4 IAPBD implementation for fermentation optimization 
5.4.1 Coordinate Agent 
Same as in previous cases, the Coordinate Agent retrieves the historical experiment data 
from database and writes the new executed experiment results into the same database. It also 
translates the information in the database in the message format to blackboard.  
 
5.4.2 Assay Agent 
Similar to the Assay Agent in Chapter 4, the agent retrieves data via a watcher program by 
monitoring specific file folder. Tecan Gemini is used in the case study to control both LHS 
and assay devices. Unlike Tecan Evoware that is used in first case study (Chapter 3), the 
software does not have API for third party integration, so the agent can only access 
experimental data by monitoring output files from Tecan Gemini. 
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5.4.3 Execution Agent 
As shown in Figure 5.5, the Execution Agent controls the devices by monitoring and 
sending data to Tecan Gemini in real time. Although Gemini does not provide API for direct 
third party integration, it provides option to open a third party executable file and take return 
values into its current running script. Thus, a communicator is introduced to send relevant 
parameters, which is volume of each media solution that required to be dispensed into each 
well, to the Gemini script when needed. Different from the case in Chapter 3, the script for 
Tecan LHS cannot be generated automatically and executed by LHS in real time. Thus, 
researcher still has to compose scripts manually to define every procedure that is needed 
during experimentation. However, because values of some parameters can be updated in real 
time from the communicator, no human intervention is needed during operation. 
 
 
Figure 5.5 Interactions among Assay Agent, Execution Agent and experiment devices. 
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5.4.4 Experiment Design Agent 
The sequential DoE method, which is explained in previous section, is integrated into 
Experiment Design Agent. In this case, the flowchart of the Experiment Design Agent is 
shown in Figure 5.6. Starting with low-resolution fractional factorial designs, the method 
will select significant factors. Based on selected factors, extra experiments will be selected 
to further investigate the response surface of the chosen factors. Finally the optimal value set 
of factors will be archived based on response surface study.  
 
 
Figure 5.6 Flowchart of Experiment Design Agent  
 
The DoE algorithm was realized from the existing functions in Matlab’s Statistics and 
Machine Learning Toolbox. The algorithm was then complied into .Net libraries in order to 
integrate into Experiment Design Agent. 
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Table 5.2 Matlab toolboxes and functions used in Experiment Design Agent 
Toolbox Name Functions Usage in IAPBD 
Statistics and Machine Learning Toolbox fracfact Fractional Factorial Design 
 bbdesign Response Surface Design 
 manova Analysis of Variances 
Optimization Toolbox fmincon Find optimal value of process 
model from DoE algorithm 
Matlab Complier SDK libraryComplier Compile Matlab functions into .net 
library, which can be called by 
IAPBD 
 
5.5 IAPBD demonstration through fermentation optimization 
For the fermentation optimization, the following results using above described methods 
have been achieved. The Execution Agent and the Assay Agent drove the TECAN liquid 
handling system and the plate reader via Tecan Gemini. The communication between the 
coordinator agent and other agents was smooth in facilitating data exchange. The 
Experiment Design Agent used the sequential DoE for process optimization.  
A global analysis of engineering variables and media components were performed. The 
Experiment Design Agent designed 32 experiment runs based on fractional factorial design, 
as shown in Table 5.3. As shown in Table 5.1, there are 12 factors included in the case 
study. The full 2-level factorial design will result in 212 experiment runs, which is 
obviously not practical. Thus a low-resolution factor screening is more preferable at early 
stage.   
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Table 5.3 Fractional factorial design for factor screening.  -1: low level, 1:high level. 
No. Peptone Yeast Glycerol MgSO4 NH4Cl Na2HPO4 K2PO4 IPTG Shaking 
Fill 
Volumn 
Induction 
Time Temperature 
1 -1 -1 -1 1 1 1 1 -1 -1 1 1 -1 
2 -1 -1 1 -1 1 -1 1 1 1 -1 1 -1 
3 -1 -1 1 1 -1 1 -1 1 -1 -1 1 -1 
4 -1 1 -1 -1 1 1 -1 -1 1 -1 -1 1 
5 -1 1 -1 1 -1 -1 -1 1 1 1 -1 1 
6 -1 1 1 -1 -1 -1 1 -1 -1 1 1 -1 
7 1 -1 -1 -1 1 -1 -1 1 -1 1 -1 1 
8 1 -1 -1 1 -1 -1 1 -1 1 -1 -1 1 
9 1 -1 1 -1 -1 1 -1 -1 1 1 -1 -1 
10 1 -1 1 -1 -1 1 -1 -1 1 1 1 1 
11 1 1 -1 -1 -1 1 1 1 -1 -1 -1 -1 
12 1 1 -1 -1 -1 1 1 1 -1 -1 1 1 
13 1 1 1 1 1 -1 -1 -1 -1 -1 -1 -1 
14 1 1 1 1 1 -1 -1 -1 -1 -1 1 1 
15 1 1 1 1 1 1 1 1 1 1 -1 -1 
16 1 1 1 1 1 1 1 1 1 1 1 1 
17 1 -1 -1 -1 1 -1 -1 1 -1 1 -1 -1 
18 -1 1 1 -1 -1 -1 1 -1 -1 1 1 1 
19 -1 -1 -1 1 1 1 1 -1 -1 1 -1 1 
20 -1 -1 1 1 -1 1 -1 1 -1 -1 1 1 
21 1 -1 -1 1 -1 -1 1 -1 1 -1 -1 -1 
22 -1 1 -1 -1 1 1 -1 -1 1 -1 1 -1 
23 -1 1 -1 1 -1 -1 -1 1 1 1 -1 -1 
24 -1 -1 1 -1 1 -1 1 1 1 -1 1 1 
25 1 -1 -1 -1 1 -1 -1 1 -1 1 1 1 
26 -1 1 1 -1 -1 -1 1 -1 -1 1 -1 -1 
27 -1 -1 1 1 -1 1 -1 1 -1 -1 -1 -1 
28 1 -1 -1 1 -1 -1 1 -1 1 -1 1 1 
29 -1 1 -1 1 -1 -1 -1 1 1 1 1 -1 
30 -1 -1 1 -1 1 -1 1 1 1 -1 -1 1 
31 1 1 -1 -1 -1 1 1 1 -1 -1 -1 1 
32 1 1 1 1 1 -1 -1 -1 -1 -1 1 -1 
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96 experiment runs (3 replicates for each experimental condition) were carried out by 
Tecan LHS. The biomass concentrations were measured afterwards. Among all 32 runs, 
the biomass concentration ranged from 0.09g/L to 4.86g/L. 
Table 5.4 ANOVA of fraction factorial design.1 
Source DF Adj SS Adj MS F-Value P-Value 
Model 12 43.09 3.5908 30.32 0 
Peptone (A) 1 0.0026 0.0026 0.02 0.883 
Yeast (B) 1 0.0091 0.0091 0.08 0.784 
Glycerol (C) 1 1.5123 1.5123 12.77 0.002 
MgSO4 (D) 1 0.155 0.155 1.31 0.267 
NH4Cl (E) 1 1.7508 1.7508 14.78 0.001 
Na2HPO4 (F) 1 0.114 0.114 0.96 0.339 
K2PO4 (G) 1 0.7215 0.7215 6.09 0.026 
IPTG (H) 1 0.4877 0.4877 4.12 0.057 
Shaking (J) 1 35.3548 35.3548 298.49 0 
Fill Volume (K) 1 1.2701 1.2701 10.72 0.004 
Induction Time (L) 1 0 0 0 0.999 
Temperature (M) 1 0.0159 0.0159 0.13 0.718 
Error 19 2.2505 0.1184   
Total 31 45.3404    
 
The ANOVA (Table 5.4) was performed after experimentation. According to ANOVA 
result, only 4 factors among 12 factors have statistically significant effect on biomass 
concentration (response factor) based on 95% confidence interval. This is also confirmed 
by factor plot shown in Figure 5.7. 
 
                                                
1 ANOVA result shown in the table is reproduced by Minitab (Minitab Inc. Pennsylvania, 
U.S.) based on raw data stored in platform’s database. In the table, DF stands for degree of 
freedom. “Adj SS” and “Adj MS” stand for adjusted sums of squares and mean squres. 
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Figure 5.7 Main factor plot of biomass concentration. A gray background represents a 
factor considered insignificant in the model. 
 
A response surface design was then generated by the Experiment Design Agent based on 
these four factors. According to Box–Behnken method, the design is a two-level full 
factorial design combined with central points for each factor. Thus, there are 27 experiment 
runs in total as shown in Table 5.5. Apart from the selected 4 factors, the values of the other 
eight factors that led to the highest biomass concentration were chosen based on the previous 
experiment results. 
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Table 5.5 Response surface design for selected four factors 
No. Glycerol NH4Cl Shaking speed Fill volume 
1 0 0 1 1 
2 -1 0 0 -1 
3 0 0 1 -1 
4 -1 1 0 0 
5 -1 0 -1 0 
6 0 -1 1 0 
7 0 0 0 0 
8 0 1 0 -1 
9 1 0 0 -1 
10 1 -1 0 0 
11 1 1 0 0 
12 0 -1 -1 0 
13 0 0 -1 1 
14 0 -1 0 -1 
15 -1 0 0 1 
16 0 1 -1 0 
17 0 0 -1 -1 
18 1 0 0 1 
19 0 1 0 1 
20 1 0 -1 0 
21 0 0 0 0 
22 1 0 1 0 
23 -1 0 1 0 
24 0 1 1 0 
25 0 -1 0 1 
26 0 0 0 0 
27 -1 -1 0 0 
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Table 5.6 Factors included in the response surface design  
Factors  High (1) Medium (0) Low (-1) 
Glycerol % w/v 1.5 0.85 0.2 
NH4Cl % w/v 0.2 0.1 0.01 
Shaking rpm 1000 700 400 
Fill Volume mL 1.5 1 0.5 
 
Execution Agent and Assay Agent then carried out the 27 experiment runs on Tecan LHS. 
The final model was generated based on ANOVA performed in Experiment Design Agent. 
The result of ANOVA is shown in Table 5.7. As seen in Table 5.7, the quadratic terms have 
no statistical significance based on 95% confidence interval, while some interaction terms 
proved to have significant effect on biomass concentration, e.g. ‘glycerol* NH4Cl’, 
‘glycerol*shaking speed’, and ‘NH4Cl*shaking speed’.  
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Table 5.7 ANOVA for response surface design on four factors: glycerol (A), NH4Cl (B), 
shaking speed (C), fill volume (D).2 
Source DF Adj SS Adj MS F-Value P-Value 
Model   14 13.5124 0.9652 144.71 0 
  Linear 4 13.1592 3.2898 493.24 0 
  A 1 0.5001 0.5001 74.98 0 
  B 1 0.0752 0.0752 11.28 0.006 
  C 1 12.1374 12.1374 1819.75 0 
  D 1 0.4465 0.4465 66.95 0 
  Square 4 0.0067 0.0017 0.25 0.903 
  A*A 1 0.0008 0.0008 0.12 0.737 
  B*B 1 0 0 0.01 0.938 
  C*C 1 0.0001 0.0001 0.02 0.899 
  D*D 1 0.0036 0.0036 0.53 0.479 
  2-Way Interaction 6 0.3464 0.0577 8.66 0.001 
  A*B 1 0.152 0.152 22.79 0 
  A*C 1 0.1096 0.1096 16.44 0.002 
  A*D 1 0.0061 0.0061 0.91 0.358 
  B*C 1 0.045 0.045 6.75 0.023 
  B*D 1 0.0051 0.0051 0.76 0.399 
  C*D 1 0.0286 0.0286 4.28 0.061 
Error   12 0.08 0.0067     
  Lack-of-Fit 10 0.0677 0.0068 1.1 0.566 
  Pure Error 2 0.0123 0.0062     
Total   26 13.5924       
 
 
                                                
2 ANOVA result shown in the table is reproduced by Minitab (Minitab Inc. Pennsylvania, 
U.S.) based on raw data stored in platform’s database. In the table, DF stands for degree of 
freedom. “Adj SS” and “Adj MS” stand for adjusted sums of squares and mean squres. 
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Figure 5.8 Response surface plot of biomass concentration on four factors: glycerol (A), 
NH4Cl (B), shaking speed (C), fill volume (D). 
 
Using stepwise method, the polynomial model has been found in Equation 5.1 with R 
squared value of 98.96%.  
 
Biomass=1.5675 + 0.2041A + 0.0792B + 1.0057 C - 0.1929D + 0.1950A*B + 0.1656A*C 
+ 0.1061B*C - 0.0845C*D                                 
 
where A stands for the concentration of glycerol, B for the concentration of NH4Cl, C for the 
shaking speed, and D for the fill volume. 
The optimal conditions for fermentation process have been found based on the equation as 
shown in Table 5.8. 
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Table 5.8 Optimal media and operating conditions for microscale fermentation 
Tryptone (g/L) 30  
Yeast (g/L) 15 
Glycerol (g/L) 90 
MgSO4 (g/L) 2 
NH4Cl (g/L) 1 
Na2HPO4 (g/L) 2 
K2PO4 (g/L) 1 
Induction Time (h) None 
Temperature (oC) 30 
Induction concentration of 
IPTG (mM) None 
Shaking (rpm) 1000 
Fill volume (ml) 0.5 
 
5.6 Comparison between tradition implementation and IAPBD 
IAPBD has demonstrated its strength to significantly reduce time consumption for 
microscale fermentation studies on automated LHS. As shown in Figure 5.9, the advantage 
of IAPBD is not obvious when performing the 1st round of experiments. It is because the 
script that controls cannot be generated dynamically as in Chapter 3 due to lack of APIs for 
LHS in this case study. Thus, same as traditional approach, researchers still have to 
manually write script to define each step that LHS need to act for experimentation, which 
takes about 1-2 days. However, the data analysis time have been shortened from half day 
into less than 1 minute due to the integration with data analysis methods in IAPBD. The real 
advantage of IAPBD appears in the 2nd iteration. Because communicator can inject updated 
parameters into scripts, no script coding and debugging is needed this time. The total time 
consumption of the second round is only 1 day instead of 2.5 days in traditional approach. 
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Figure 5.9 Time consumption in the traditional approach and IAPBD 
 
5.7 Effect of dissolved oxygen in fermentation 
As shown in Equation 5.1, biomass growth was promoted by any factor that would increase 
oxygen availability like lower fill volume, higher shaking speeds and higher temperature. In 
order to further study this factor in isolation from all the other factors, Dr. L. Rios-Solis 
carried out an experiment run manually. Using a microscale DOT probe constructed in our 
department, the DOT was measured for a microscale fermentation using the selected 
conditions from DoE results. Figure 5.10 shows the resulting DOT profile as well as the 
biomass growth kinetics. The microscale fermentation in Figure 11 was oxygen limited as 
the DOT falled to 0% after 45 min when the early exponential phase begun, and remained at 
0% until the stationary phase. This is in agreement with recently published works that the 
limitation of dissolved oxygen plays an import role for final biomass growth in microscale 
fermentation (Kirk & Szita 2013). 
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Figure 5.10 Microscale fermentation following  (•) DOT (%) and (▲) biomass (gDCW l-1) 
using the selected fermentation conditions shown in where A stands for the concentration of 
glycerol, B for the concentration of NH4Cl, C for shaking speed, and D for fill volume.  
 
5.8 Pilot scale verification  
A 5L fermentation experiment was performed to evaluate the optimized condition from 
microscale fermentation studies The media component used in the 5L fermentation is shown 
in Table 5.8. A fermentation using LB media was also carried out as the control.  
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Figure 5.11 The biomass growth in the 5L fermentation using (▲) selected media from 
Table 10 and (■) LB. (♦) is the DOT for the selected media 
 
As shown in Figure 5.11, the fermentation with the optimized conditions reached a biomass 
of 58 gDCW l-1 in 40 hr with a specific growth rate of 0.65 hr-1, while the fermentation with 
LB reached a biomass 5.5 times lower with a specific growth rate of 0.23 hr-1. The better 
performance with optimized conditions further proved that the microscale fermentation 
driven by the automation platform is capable of upstream process study. 
 
5.9 Conclusions 
5.9.1 Evaluation of IAPBD 
The prototype of the intelligent automation platform to perform fermentation experiments 
automatically has been established. The platform is able to drive liquid handling robotic arm, 
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shaker and plate reader together to perform all the procedures without human involvement.  
The closed-loop learning was achieved by using the sequential DoE method that the 
experiments were selected iteratively until the final design solution was found. The platform 
selects initial experiments based on factorial DoE, executes experiments and assays by 
automated devices, and carries out data analysis by experiment design algorithm to identify 
the next batch of experiments. The case study has proven that besides simplex search and 
neural network, various algorithms can be applied in the platform based on the requirement 
of research. The DoE algorithm shows its power when modelling the relationship among 
several variables and response factor. Starting with simple media optimization, the platform 
is capable to model the whole microscale fermentation process involving nearly 20 different 
variables. 
The integration of experiment devices, database, and algorithms for experiment design 
demonstrates a powerful tool for high throughput process development for not only 
downstream unit operation but also upstream fermentation process. Although current 
devices can provide high throughput, the brute force experiment design may still lead to 
unnecessary waste of time and material. The ‘intelligent’ experimental design by these 
algorithms, however, can keep the number of experiments low. The elimination of time 
delay during experiment procedure and utilization of intelligent experiment design in 
intelligent automation platform has reduced time needed and makes the platform a very 
effective process optimization tool. 
 
5.9.2 Fermentation process optimization 
The case study showed operating conditions play more important roles in biomass growth in 
microwell plate. Shaking speed and fill volume have significant effect for microscale E. coli 
fermentation. This is because these two factors have positive relation with dissolved oxygen 
in media. Later experiments confirmed that cell growth largely limited by dissolved oxygen 
in deep well plate. Although it does not matter which types of carbon and nitrogen source 
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supplied in the media, the quantity of nutrition is essential to E. coli because quantities of 
glycerol and NH4Cl are proved to be the statistically significant factors. 
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Chapter 6 Conclusions and future work 
 
6.1 Conclusions 
Bioprocess development is very labour intensive, requiring many experiments to 
characterize each unit operation in the process sequence to achieve product safety and 
process efficiency. Recent advances in microscale biochemical engineering have led to 
automated high throughput experimentation. The activities in bioprocess development are 
implemented sequentially in which 1) liquid handling system performs the wet lab 
experiments; 2) standalone analytical devices detect the data; and 3) specific software is 
used for data analysis and experiment design. The experiment design, data analysis and 
process understanding requires substantial engineer’s time and becomes one of the 
bottlenecks in automated experimentation when a high number of experiments is needed to 
explore a large design space in order to discover a high process performance. A whole 
bioprocess often involves a sequence of unit operations. The whole bioprocess design 
approach will require very large amount of experimental work to understand process 
interactions.  
This thesis has addressed the challenge to reduce the development time and cost without 
compromising the process efficiency. To increase the process efficiency, a large design 
space with wide ranges has been explored through micro scale high throughput 
experimentation. To reduce the development time and cost, a closed-loop learning approach 
has been adopted in bioprocess design in which the design objectives are driven iteratively 
by intelligent data acquisition algorithms. In this way fewer number of information rich 
experiments are needed yet without compromising the process performance. In addition, 
artificial intelligence technology has been used to transform all manual operations in data 
processing, experiment design, process evaluation, programming and data management into 
automation. A framework that brings all of the elements performed manually into an 
automated fashion has been established to deliver the closed-loop learning approach. This 
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includes the physical devices that carry out experiment preparation, experiment execution, 
assays, and different types of software that drives each device. In addition utilization of 
intelligent algorithms for process evaluation, prediction and optimization as well as 
automation is designed to reduce the process development time and enhance the process 
efficiency. Based on the framework, a novel prototype of Intelligent Automation Platform 
for Bioprocess Development (IAPBD) has been built using multi-agent architecture. A 
rational database and four agents including Coordinate Agent, Experiment Design Agent, 
Execution Agent and Assay Agent have been designed to perform individual tasks and 
worked as a team to deliver the bioprocess design objectives. The multi-agent architecture 
used a blackboard mechanism. The architecture has been chosen to control all of the 
software to realize the closed-loop learning. The blackboard mechanism is employed as a 
communication mechanism to connect the four agents so that they are able to communicate 
with each other during operations. The blackboard is a place that all agents can publish and 
read all relevant data in XML format. 
Starting with the objective and a set of initial experiments from the user or database, IAPBD 
is able to drive the robotic arm to perform defined initial experiments, and drive the 
analytical devices to detect the data after the experiments are completed. Then it will pick up 
the data from the analytical devices, and carry out data processing and process evaluation 
based on the optimization objective to achieve the design solution. After evaluation of the 
design solution, the platform will decide to stop or continue to design the next round 
experiments for optimization.  
The data structure of experiment and data structure of device information have been 
designed and presented to fit the experiment data sharing purpose. Data are stored using 
Entity-Relationship model in the database for easy information search and communication. 
The Experiment Execution Agent has been designed to manage the experiment tasks and the 
connections with robotic arm LHS and other automated devices such as labware. The agent 
use programmable interfaces in the automated devices, “translator” algorithm and “watcher” 
algorithm to connect with the hardware. The Experiment Design Agent is responsible of 
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designing experiments and publishing them on blackboard. It has a set of experiment design 
algorithms to use and a general interface to communicate with these algorithms. The Assay 
Agent is tasked to manage the analytical instruments. The agent also used programmable 
interface and “watcher” algorithm to connect with the analytical devices. For HPLC, the 
k-mean cluster algorithm has been developed to turn the HPLC raw data into the 
measurement. The Coordinate Agent manages the database by retrieving historical 
experiment data and configuration data, writing new executed experiment information into 
the database, and manages the information published on blackboard. The communication 
among the agents is realised by sending and reading messages with defined data structure in 
XML format to the blackboard. This can eliminate manual operations to improve efficiency 
and accuracy of experimentation and data analysis during bioprocess design. 
The prototype has been evaluated firstly by a lysozyme precipitation process design, which 
involves typical microscale experimental procedures such as mixing, shaking, sample 
preparation and high throughput data detection instruments. All of the devices used have 
programmable interfaces so agents can control them directly. The detailed designs for each 
agent have been illustrated through this example.  
The goal of the experiment is to find an optimal design that maximizes the yield of lysozyme 
and maximizes the ammonium sulphate concentration by examining pH and ammonium 
sulphate concentration. An objective function that combines the yield and the ammonium 
sulphate concentration has been mathematically formulated. The case study is deliberately 
chosen for its simplicity so as to illustrate the functions of IAPBD. The experiment has 
several common operations in most of biochemical experiments such as mixing, shaking, 
incubation, filtration for sample preparation and a plate reader as a high throughput data 
detection instrument. All of the devices used have programmable interfaces so agents can 
control them directly. The detailed designs for each agent have been illustrated through this 
example. In this case study, the multi-agent architecture is proven to be able to drive liquid 
handling robotic arm, vacuum pump, shaker and plate reader together to perform all the 
procedures such as assembly adding, shaking, incubation, UV absorption measurement 
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automatically. Both the simplex search algorithm and the artificial neural network algorithm 
for experiment design have been implemented in the Experiment Design Agent. The closed 
loop learning was achieved by using simplex search algorithm and artificial neural network 
modelling in which the experiments were selected iteratively until the final design solution 
was found based on the objective function.  
Starting with three randomly chosen experiments, the Experiment Design Agent used 
simplex search method and found the optimal point after 16 iterations. The maximum value 
of objective function was 0.70, and the ammonium sulphate concentration was 0.8 mol/L 
and the pH was 7.1. The Experiment Design Agent using the ANN method found optimal 
point after 4 iterations with 20 experiments executed by IAPBD. The optimal point was at 
0.7 mol/L of ammonium sulfate concentration and pH of 7.0, which is very close to the one 
found by simplex search algorithm. These case studies showed that IAPBD is capable of 
integrating automated devices and intelligent algorithm together to complete biochemical 
experiments for process development automatically without human intervention. The 
success of these case studies proved the concept of IAPBD. 
The second case study was designed to verify the capacity of IAPBD when integrating with 
isolated instruments, which do not have programmable interface, and to investigate the 
interaction between two step operations, i.e. anion exchange chromatography and 
precipitation for monoclonal antibody purification. In this work HPLC was required to 
quantify antibody concentrations but HPLC does not have the programmable interface for 
connection.  
The integration with HPLC was achieved by two algorithms. The first one is a “file watcher” 
algorithm that monitors the location where ChemStation outputs its raw data files, and 
reports the latest raw data to the Assay Agent once there is a new file generated. The second 
is K-mean clustering algorithm that is used to translate the raw data of retention time and 
peak area into the protein concentration. 
After the integration with HPLC has achieved, two sets of experiments were performed on 
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IAPBD to examine the interaction between the anion exchange chromatography and the 
precipitation.  
The first experiment was a simple mAb precipitation optimization carried out on IAPBD 
with simplex search algorithm. The results achieved by IAPBD have been verified by 
previous work done manually. This has verified that IAPBD can perform the precipitation 
process optimization automatically and accurately. In the next experiment, the feedstock 
went through AEX first using a set of conditions optimized manually. The material collected 
from the elution was used as the feedstock for the 2nd round mAb precipitation optimization. 
The impurity of the new feedstock has been reduced almost 50%. The results from two 
experiments turned out to be slightly different. According to the results, in the 2nd 
experiment, there was 6.3% potential gain in mAb purity while only 2.6% yield was 
sacrificed. Thus, the interaction between precipitation and AEX does exist based on the 
experiments. IAPBD carried out two sets of precipitation experiments automatically and 
discovered the interaction between precipitation and anion exchange chromatography exist 
so that the integrated process design for two steps may achieve better results.  
IAPBD operated smoothly during the case study. It controlled all the relevant automated 
instruments to execute the experiments automatically, and the “File Watcher” algorithm for 
connecting with HPLC has been proven robust and efficient to retrieve the data from HPLC.  
The third case study is designed to use the sequential Design of Experiment method to 
optimize the production of a whole cell biocatalyst in fermentation. A different automation 
platform, Tecan Gemini, was used to satisfy the sterilisation requirement for fermentation. 
However the LHS has no programmable interface, which provides a challenge for 
communication that may happen in other devices. In order to communicate with LHS in 
sample preparation step, a “translator” algorithm acted as a communicator was programmed 
in Execution Agent to send relevant information to Gemini, i.e. the software that drives 
Tecan LHS.  
The algorithm of the sequential DoE methods has been coded as one of the experiment 
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design method in the Experiment Design Agent. The fermentation optimization aiming to 
maximize the biomass concentration hence the intracellular biocatalyst titre has been 
achieved automatically by IAPBD. IAPBD performed a general factor screening with 12 
factors including both media components and operating conditions. An optimal solution for 
medium composition and operating conditions was found successfully after two iterations, 
based on a polynomial model established by the Experiment Design Agent. It was then 
confirmed by the large scale fermentation experiment that the optimal solution has 
outperformed normal LB medium and the biomass has been increased 5.5 folds. IAPBD 
worked smoothly during the operations, and it proved to be time efficient. 
In summary, a prototype of IAPBD has been built by using the multi-agent architecture and 
the closed-loop learning framework for bioprocess design has been realised. IAPBD is 
capable of interacting with robotic arm LHS, isolated instruments to perform bioprocess 
optimization automatically at microscale. Three case studies further demonstrated that 
IAPBD’s capacity in both upstream and downstream process design. The benefit of this 
novel IAPBD is its automation that reduces the bioprocess design time significantly and 
frees engineer’s time for other intellectual tasks. With further development and evaluation, 
its potential to reduce the time and cost of the whole bioprocess development can be 
realised.  
 
6.2 Future work 
This thesis is the first step to develop the intelligent automation platform for bioprocess 
design. Although the prove-concept has been achieved, further development is anticipated to 
improve the technology toward commercialisation to realise its true value. Four areas have 
been identified and recommendations on further researches have been made. 
6.2.1 Applications of microscale chromatography optimization on IAPBD 
IAPBD has the potential to be used in any bioprocess unit operations when they can be 
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studied in microwell plate and robotic LHS. In downstream process studies, the thesis only 
covered precipitation in two case studies. However, chromatography plays an even more 
important role in current downstream purification process. The number of parameters in 
chromatography process (e.g. binding buffer conditions, elution buffer conditions, flow rate, 
etc.) is much more than that in precipitation. The benefit of automated execution and 
analysis is obvious since the number of experiments required for process development 
grows exponentially with number of parameters. As mentioned in Chapter 1, several 
researchers have reported that chromatography can be studied at microscale using robotic 
LHS. IAPBD has potential to gain better performance comparing with manual operation as 
the number of parameters increases. Thus using IAPBD for chromatography process 
parameter screening and design optimization will be an interesting research activity to 
evaluate its capability.

6.2.2 Optimized planning and scheduling functionalities during experiment execution 
The efficiency of experiment execution and assay operations can be further improved if 
advanced planning and scheduling functionalities is introduced in IAPBD. Currently, only 
one type of experiment has been tested at one time on IAPBD. For example, while IAPBD is 
running mAb precipitation experiments, no other experiments are planned to run 
deliberately. In fact, most time is spent on incubation or mixing in bioprocess experiments 
when LHS stays idle. It is possible to assign some sample preparation tasks to LHS during 
this time period so that IAPBD is able to carry out more experiments and multiple tasks in 
bioprocess design may be achieved at the same time. This can potentially reduce whole 
process development time significantly.  
Advanced planning and scheduling techniques will be required for IAPBD when handling 
several different types of experiments in order to fully utilize the capacity of those 
automated instruments. This is because the time consumption of each experimental task is 
different and some tasks are dependent on the completion of other tasks. For example, in 
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mAb precipitation experiments, feedstock cannot be dispensed into microwell plate before 
the buffer solution has been added. The techniques will be able to identify which tasks can 
be executed in parallel from all tasks to be performed. Actually, similar problems have been 
studied intensively in the fields like manufacturing scheduling and supply chain 
management. A few of methods have been development in recent years to tackle those 
challenges, e.g. mixed integer programing and genetic algorithms. Thus, it is promising to 
integrate IAPBD with those advanced planning techniques to improve the utilization of the 
resources in bioprocess development. 
 
6.2.3 Integration with knowledge engineering techniques 
The knowledge and data base module in IAPBD can be further improved by integrating 
sophisticated knowledge engineering techniques. Currently, IAPBD’s database only 
accumulates historical experiment data that was generated from itself. However, the amount 
of data available from other sources has increased exponentially since the expansion of new 
biopharmaceutical development. The development time can be significantly reduced if 
IAPBD is able to take advantage of all relevant data from other sources (e.g. previous 
research papers).  
Sophisticated knowledge engineering and data mining techniques will help IAPBD better 
understand the data available. Currently, data in bioprocess studies are heterogeneous, 
sometimes inconsistent and incomplete. This makes it difficult to be systematically utilized 
for analysis for bioprocess development. Thus, techniques that can systematically analyse 
data would benefit IAPBD significantly. Some applications of implementing knowledge 
engineering into bioprocess development have been reported recently (Zhang, Hunter, & 
Zhou, 2013). The technique is able to represent the data into a novel data structure for 
experimental data that can be analysed systematically. Logic reasoning based algorithm has 
been introduced to generate suggestions for bioprocess development according to historical 
data.  
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Historical objective functions from the advanced knowledge base can support researchers 
make decisions on design objectives. This will enable IAPBD’s Experiment Design Agent 
works more closely with the knowledge base to make decision easier and quicker. 
 
6.2.4 Whole process design and optimization on IAPBD 
Each unit operation was studies separately currently on IAPBD, although the second case 
study in the thesis tried to investigate the interaction between two different operations. The 
manufacture of biopharmaceutical products is normally composed of several bioprocess 
including upstream and downstream operations. In most cases, tradeoffs among different 
processes and objectives are required when expanding to whole process optimization. The 
whole process design and optimization cannot be achieved by simply adding together all 
designs based on the single unit operation. 
However, if most unit operations now can be studied in mirowell plate on robotic 
instruments, it should be possible to perform multiple process steps on IAPBD continuously 
from upstream fermentation to downstream purification. The capacity of IAPBD will be 
further utilized since the number of parameters will increase dramatically if the whole 
process is studied at the same time.   
Alternatively, since IAPBD’s knowledge base is able to store all the historical data and 
statistical models, the whole process can be described by a group of statistical models with 
multiple design space and constraints. Thus, multi-agent architecture can be expanded as 
described in Chapter 1. We can develop more process design agents who possess specific 
process knowledge of unit operations. The whole process design can be achieved through 
discussion and argumentation among all these agents.  
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Appendix I Raw data for E. coli fermentatio
1 General factor optimization: 1nd iteration 
Factor values are normalized from -1 to 1. 
Peptone Yeast Glycerol MgSO4 NH4Cl Na2HPO4 K2PO4 IPTG Shaking Fill Volumn Induction Time Temperature Biomass (g l-1) 
-1 -1 -1 1 1 1 1 -1 -1 1 1 -1 0.48 
-1 -1 1 -1 1 -1 1 1 1 -1 1 -1 3.53 
-1 -1 1 1 -1 1 -1 1 -1 -1 1 -1 0.86 
-1 1 -1 -1 1 1 -1 -1 1 -1 -1 1 2.84 
-1 1 -1 1 -1 -1 -1 1 1 1 -1 1 1.91 
-1 1 1 -1 -1 -1 1 -1 -1 1 1 -1 0.52 
1 -1 -1 -1 1 -1 -1 1 -1 1 -1 1 0.21 
1 -1 -1 1 -1 -1 1 -1 1 -1 -1 1 2.24 
1 -1 1 -1 -1 1 -1 -1 1 1 -1 -1 1.98 
1 -1 1 -1 -1 1 -1 -1 1 1 1 1 2.53 
1 1 -1 -1 -1 1 1 1 -1 -1 -1 -1 0.46 
1 1 -1 -1 -1 1 1 1 -1 -1 1 1 0.23 
1 1 1 1 1 -1 -1 -1 -1 -1 -1 -1 1.41 
1 1 1 1 1 -1 -1 -1 -1 -1 1 1 0.69 
1 1 1 1 1 1 1 1 1 1 -1 -1 2.69 
1 1 1 1 1 1 1 1 1 1 1 1 3.20 
1 -1 -1 -1 1 -1 -1 1 -1 1 -1 -1 0.42 
-1 1 1 -1 -1 -1 1 -1 -1 1 1 1 0.33 
-1 -1 -1 1 1 1 1 -1 -1 1 -1 1 0.14 
-1 -1 1 1 -1 1 -1 1 -1 -1 1 1 0.22 
1 -1 -1 1 -1 -1 1 -1 1 -1 -1 -1 2.32 
-1 1 -1 -1 1 1 -1 -1 1 -1 1 -1 2.15 
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-1 1 -1 1 -1 -1 -1 1 1 1 -1 -1 2.08 
-1 -1 1 -1 1 -1 1 1 1 -1 1 1 4.24 
1 -1 -1 -1 1 -1 -1 1 -1 1 1 1 0.30 
-1 1 1 -1 -1 -1 1 -1 -1 1 -1 -1 0.31 
-1 -1 1 1 -1 1 -1 1 -1 -1 -1 -1 0.23 
1 -1 -1 1 -1 -1 1 -1 1 -1 1 1 2.34 
-1 1 -1 1 -1 -1 -1 1 1 1 1 -1 2.11 
-1 -1 1 -1 1 -1 1 1 1 -1 -1 1 3.65 
1 1 -1 -1 -1 1 1 1 -1 -1 -1 1 1.16 
1 1 1 1 1 -1 -1 -1 -1 -1 1 -1 0.77 
  
2 General factor optimization: 2nd iteration 
glycerol (A), NH4Cl (B), shaking speed (C), fill volume (D). Values are normalized 
from -1 to 1. 
A B C D Biomass (g l-1) 
0 0 1 1 2.30 
-1 0 0 -1 1.56 
0 0 1 -1 2.80 
-1 1 0 0 1.29 
-1 0 -1 0 0.48 
0 -1 1 0 2.48 
0 0 0 0 1.65 
0 1 0 -1 1.85 
1 0 0 -1 2.08 
1 -1 0 0 1.43 
1 1 0 0 2.03 
0 -1 -1 0 0.54 
0 0 -1 1 0.55 
0 -1 0 -1 1.67 
-1 0 0 1 1.22 
0 1 -1 0 0.49 
0 0 -1 -1 0.71 
1 0 0 1 1.58 
0 1 0 1 1.36 
1 0 -1 0 0.59 
0 0 0 0 1.55 
1 0 1 0 2.87 
-1 0 1 0 2.11 
0 1 1 0 2.86 
0 -1 0 1 1.33 
0 0 0 0 1.49 
-1 -1 0 0 1.47 
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Appendix II Paper by the Author 
